Naked Brand (NAKD) 10-K 15 May 14 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Jan. 31, 2014	15-May-14	Jul. 31, 2013
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Jan-14	'	'
Trading Symbol	'nakd	'	'
Entity Registrant Name	'NAKED BRAND GROUP INC.	'	'
Entity Central Index Key	'0001383097	'	'
Current Fiscal Year End Date	'--07-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Common Stock, Shares Outstanding	'	35,983,674	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Well Known Seasoned Issuer	'No	'	'
Entity Public Float	'	'	$23,177,418
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'FY	'	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Jan. 31, 2014	Jan. 31, 2013
Current assets	'	'
Cash	$67,478	$43,780
Accounts receivable, net of allowance for doubtful accounts of $1,652 and $4,899, respectively	68,859	404,713
Advances receivable	50,000	0
Inventory	604,046	236,150
Prepaid expenses	70,666	47,148
Total current assets	861,049	731,791
Equipment, net	6,300	1,842
Intangible assets, net	39,877	55,414
Deferred financing fees	65,539	198,538
TOTAL ASSETS	972,765	987,585
Current liabilities	'	'
Accounts payable and accrued liabilities	639,099	306,467
Related party payables	0	13,916
Promissory notes payable	397,422	0
Current portion of convertible promissory notes	1,022,294	483,950
Derivative financial instruments	241,618	0
Total current liabilities	2,300,433	804,333
Convertible promissory notes	1,670	0
TOTAL LIABILITIES	2,302,103	804,333
STOCKHOLDERS' EQUITY (CAPITAL DEFICIT)	'	'
Common stock Authorized 100,000,000 common shares, par value $0.001 per share (January 31, 2013: 100,000,000 common shares, par value $0.001 per share) Issued and outstanding 34,728,139 common shares (January 31, 2013: 28,522,000)	34,728	28,522
Common stock to be issued	7,500	3,750
Accumulated paid-in capital	4,874,095	2,158,151
Accumulated deficit	-6,239,416	-2,000,926
Accumulated other comprehensive income (loss)	-6,245	-6,245
Total stockholders' equity (capital deficit)	-1,329,338	183,252
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$972,765	$987,585

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Jan. 31, 2014	Jan. 31, 2013
Allowance for Doubtful Accounts Receivable, Current	$1,652	$4,899
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Par Value Per Share	$0.00	$0.00
Common Stock, Shares, Issued	34,728,139	28,522,000
Common Stock, Shares, Outstanding	34,728,139	28,522,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Comprehensive Loss (USD $)	12 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
Net sales	$639,107	$566,508
Cost of sales	587,639	342,659
Gross profit	51,468	223,849
Operating Expenses	'	'
General and administrative expenses	2,830,661	1,440,255
Foreign exchange	14,426	23,752
Total operating expenses	2,845,087	1,464,007
Operating loss	-2,793,619	-1,240,158
Other income (expense)	'	'
Interest	-77,381	-34,853
Accretion of debt discounts and finance charges	-737,595	-57,985
Derivative expense	-170,500	0
Loss on extinguishment of debt	-468,753	0
Change in fair value of derivative financial instruments	9,358	0
Total other income (expense)	-1,444,871	-92,838
Net loss for the period	-4,238,490	-1,332,996
Basic and diluted net loss per share	($0.14)	($0.07)
Other comprehensive income (expense)	'	'
Foreign currency translation adjustments, net of tax	0	3,227
Comprehensive loss	($4,238,490)	($1,329,769)
Weighted average shares used in computing basic and diluted net loss per share	31,418,517	20,363,483

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Stockholders' Equity (Deficiency) (USD $)	Common Stock [Member]	Accumulated Paid-In Capital [Member]	Common stock to be issued [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Beginning Balance at Jan. 31, 2012	$638,972	'	'	($667,930)	($9,472)	($38,430)
Beginning Balance (Shares) at Jan. 31, 2012	6,069,251	'	'	'	'	'
Issuance of common stock for services, Class E, net	42,206	'	'	'	'	42,206
Issuance of common stock for services, Class E, net (Shares)	161,068	'	'	'	'	'
Issuance of common stock for extinguishment of debt, Class E, net	15,486	'	'	'	'	15,486
Issuance of common stock for extinguishment of debt, Class E, net (Shares)	63,321	'	'	'	'	'
Exchange of shares	-683,164	683,164	'	'	'	'
Exchange of shares (Shares)	7,206,360	'	'	'	'	'
Acquisition of Search by Headlines.com Corp.	13,508	602,783	'	'	'	616,291
Acquisition of Search by Headlines.com Corp. (Shares)	13,508,000	'	'	'	'	'
Modification of share purchase warrants	'	20,000	'	'	'	20,000
Finders fee	'	-34,951	'	'	'	-34,951
Private placement - at $0.50	214	106,786	'	'	'	107,000
Private placement - at $0.50 (Shares)	214,000	'	'	'	'	'
Private placement - at $0.25	1,300	324,716	'	'	'	326,016
Private placement - at $0.25 (Shares)	1,300,000	'	'	'	'	'
Offering costs	'	-21,055	'	'	'	-21,055
Issuance of detachable warrants	'	20,940	'	'	'	20,940
Agent's warrants - convertible promissory notes	'	237,500	'	'	'	237,500
Stock based compensation	'	218,268	3,750	'	'	222,018
Changes in foreign currency translation gains and losses	'	'	'	'	3,227	3,227
Net loss for the period	'	'	'	-1,332,996	'	-1,332,996
Ending Balance at Jan. 31, 2013	28,522	2,158,151	3,750	-2,000,926	-6,245	183,252
Ending Balance (Shares) at Jan. 31, 2013	28,522,000	'	'	'	'	'
Shares issued pursuant to private placement repricing	214	239,466	'	'	'	239,680
Shares issued pursuant to private placement repricing (Shares)	214,000	'	'	'	'	'
Shareholder dividend	'	-239,680	'	'	'	-239,680
Private placements	3,333	679,917	'	'	'	683,250
Private placements (Shares)	3,333,000	'	'	'	'	'
Offering costs	'	-26,610	'	'	'	-26,610
Shares issued/to be issued in exchange for services rendered	645	143,644	3,750	'	'	148,039
Shares issued/to be issued in exchange for services rendered (Shares)	644,843	'	'	'	'	'
Modification of convertible debt terms and warrants	'	485,704	'	'	'	485,704
Shares issued/to be issued in connection with promissory notes	402	132,118	'	'	'	132,520
Shares issued/to be issued in connection with promissory notes (Shares)	402,000	'	'	'	'	'
Warrants issued in connection with promissory notes	'	18,400	'	'	'	18,400
Shares issued under equity line with Lincoln Park	1,520	298,480	'	'	'	300,000
Shares issued under equity line with Lincoln Park (Shares)	1,519,500	'	'	'	'	'
Less: issuance costs	'	-58,656	'	'	'	-58,656
Shares issued in settlement of debt	92	7,221	'	'	'	7,313
Shares issued in settlement of debt (Shares)	92,796	'	'	'	'	'
Issuance of detachable warrants	'	41,225	'	'	'	41,225
Beneficial conversion feature	'	17,600	'	'	'	17,600
Agent's warrants - convertible promissory notes	'	67,600	'	'	'	67,600
Derivative financial instrument reclassification	'	177,900	'	'	'	177,900
Stock based compensation	'	731,615	'	'	'	731,615
Changes in foreign currency translation gains and losses	'	'	'	'	'	0
Net loss for the period	'	'	'	-4,238,490	'	-4,238,490
Ending Balance at Jan. 31, 2014	$34,728	$4,874,095	$7,500	($6,239,416)	($6,245)	($1,329,338)
Ending Balance (Shares) at Jan. 31, 2014	34,728,139	'	'	'	'	'

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
Cash flows from operating activities	'	'
Net loss	($4,238,490)	($1,332,996)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Provision for doubtful accounts	-3,247	3,443
Depreciation and amortization	22,748	11,685
Other items not involving cash	2,218,214	336,209
Unrealized foreign exchange	-2,984	0
Increase (decrease) in cash resulting from change in:	'	'
Accounts receivable	339,101	-335,933
Advances receivable	-50,000	0
Prepaid expenses	-23,518	-42,837
Inventory	-367,896	-166,456
Accounts payable	356,974	60,301
Finance fees paid in connection with debt extinguishment	-2,520	0
Net cash used in operating activities	-1,751,618	-1,466,584
Cash flows from investing activities	'	'
Acquisition of intangible assets	-5,517	-40,004
Purchase of equipment	-6,230	-2,968
Cash acquired from Search By Headlines.com Corp.	0	386,790
Net cash provided by (used in) investing activities	-11,747	343,818
Cash flows from financing activities	'	'
Proceeds from share issuances	983,250	433,016
Less: Offering costs	-85,266	-21,055
Advances from Search by Headlines.com Corp prior to the merger	0	325,000
Acquisition costs	0	-34,951
Proceeds from the issuance of promissory notes	571,122	0
Repayments of promissory notes	-199,897	-9,193
Proceeds from convertible promissory notes	958,500	500,000
Repayments of convertible promissory notes	-381,177	0
Less: Debt offering costs	-45,553	0
Repayments on debt factoring arrangements	0	-31,555
Repayments of related party payables	-13,916	-48,883
Net cash provided by financing activities	1,787,063	1,112,379
Effect of exchange rate changes on cash	0	3,811
Net increase (decrease) in cash	23,698	-6,576
Cash at beginning of the period	43,780	50,356
Cash at end of the period	67,478	43,780
Cash paid during the period for:	'	'
Interest	65,148	24,517
Taxes	0	0
Non-cash financing activities:	'	'
Extinguishment of accounts payable with equity	39,820	15,486
Conversion of related party payable to equity	0	375,000
Accounts payable - Search By Headlines.com Corp	0	153,632
Discount on debt financing	127,220	20,940
Deferred financing costs	88,400	237,500
Repayment of promissory note through issuance of new promissory note	21,562	0
Profit and loss items not involving cash consists of:	'	'
Shares issued for services	140,539	0
Shares to be issued in exchange for services	7,500	45,956
Loss on extinguishment of debt	468,753	0
Stock based compensation	731,615	238,268
Derivative expense	170,500	0
Change in fair value of derivative	-9,358	0
Amortization of deferred financing fees	269,472	38,962
Interest capitalized to convertible debt	1,365	0
Shares issued as penalty under debt agreements	2,900	0
Interest on Search by Headlines.com Corp loan forgiven	0	8,133
Accretion of debt discount	434,928	4,890
Total Other items not involving cash	$2,218,214	$336,209

Organization_and_Nature_of_Bus

Organization and Nature of Business	12 Months Ended
	Jan. 31, 2014
Organization and Nature of Business [Text Block]	'
	1.        Organization and Nature of Business
	Naked Brand Group Inc. (the “Company”) was incorporated in the State of Nevada on May 17, 2005, as Search By Headlines.com Corp. with 100,000,000 authorized common shares with a par value of $0.001 per share. During the year ended July 31, 2010, the Company ceased operations as a specialized internet search engine that featured news in a format that allowed users to search or submit news by headline. On July 30, 2012, the Company closed an Acquisition Agreement with Naked Inc. (formerly Naked Boxer Brief Clothing Inc.) (“Naked”) whereby Naked’s owners became the sole directors of the Company and Naked stockholders exchanged their shares for a total of 13.5 million shares of the Company, representing 50% of the Company (the “Acquisition”). On the same date, the entire management of Naked became the entire management of the Company. Effective August 29, 2012, the Company completed a merger with a subsidiary, Naked Brand Group Inc., a Nevada corporation, which was incorporated solely to effect a change of name. As a result, the Company changed its name from “Search By Headlines.com Corp.” to “Naked Brand Group Inc.”.
	Naked was incorporated under the federal laws of Canada on May 21, 2009 as In Search of Solutions Inc. and changed its corporate name on May 17, 2010 to Naked Boxer Brief Clothing Inc. On February 20, 2013, Naked changed its name to Naked Inc. Naked commenced business operations on February 1, 2010 as a manufacturer and seller of direct and wholesale undergarments in Canada to consumers and retailers and has been realizing revenues from its operations since September, 2010.
	As a result of the Acquisition, Naked became a wholly-owned subsidiary of the Company and the Company’s business became the manufacture and sales of direct and wholesale undergarments in Canada and the United States to consumers and retailers. The Company operates out of Abbotsford, British Columbia, Canada.

Ability_to_Continue_as_a_Going

Ability to Continue as a Going Concern	12 Months Ended
	Jan. 31, 2014
Ability to Continue as a Going Concern [Text Block]	'
	2.        Ability to Continue as a Going Concern
	These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) on a going concern basis, which assumes that the Company will continue to realize its assets and discharge its obligations and commitments in the normal course of operations. Realization values may be substantially different from carrying values as shown and these consolidated financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern.
	As at January 31, 2014, the Company had not yet achieved profitable operations, had a working capital deficiency, was in default with respect to certain loan agreements (Note 11 (i)) and expects to incur further losses in the development of its business, which casts substantial doubt about the Company’s ability to continue as a going concern. To remain a going concern, the Company will be required to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations as they come due. Management plans to obtain the necessary financing through the issuance of equity or debt to existing shareholders. Should the Company not be able to obtain this financing, it may need to substantially scale back operations or cease business. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Jan. 31, 2014
Summary of Significant Accounting Policies [Text Block]	'
	3.        Summary of Significant Accounting Policies
	Principles of Consolidation and Basis of Accounting
	These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Naked. All inter-company transactions and balances were eliminated.
	Reporting Currency and Foreign Currency
	The functional currency of the Company is the US dollar. Transaction amounts denominated in foreign currencies are translated into their US dollar equivalents at exchange rates prevailing at the transaction dates. Foreign currency gains and losses on transactions or settlements are recognized in the consolidated statement of operations.
	The functional currency of Naked changed from Canadian dollars to US dollars on November 1, 2012, triggered by a shift in cash flows from operations and an accumulation of other factors. Balances denominated in foreign currencies were re-measured at the date of change using the exchange rate in effect on that date. Revenue and expense items were translated at average rates for the period up to the date of change and translation adjustments accumulated in other comprehensive income up to the date of change were retained in that account.
	These financial statements have been presented in US dollars, which is the Company’s reporting currency. Prior to the change in functional currency during the year ended January 31, 2013, financial statements of foreign operations for which the functional currency is the local currency are translated into US dollars with assets and liabilities translated at the current rate on the balance sheet date and revenue and expense items translated at the average rates for the period. Translation adjustments are recorded as accumulated other comprehensive income (loss) in stockholders’ equity.
	Basis of Presentation
	The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in accordance with GAAP.
	Segment Reporting
	The Company used several factors in identifying and analyzing reportable segments, including the basis of organization, such as differences in products and services, and geographical areas. Our chief operating decision makers review financial information presented on a consolidated basis for the purposes of making operating decisions and assessing financing performance. Accordingly, the Company has determined that as of January 31, 2014 and 2013, there is only a single reportable operating segment.
	The Company operates in one industry, the manufacture and sale of direct and wholesale undergarments. Revenues from external customers are all derived from customers located within North America as follows:
			2014			2013
	United States	$	394,867		$	410,012
	Canada		244,240			156,496
		$	639,107		$	566,508
	At January 31, 2014 and 2013 substantially all of the Company’s long-lived assets were located in Canada.
	Revenue Recognition, Accounts Receivable and Allowance for Doubtful Accounts
	Sales are recorded when title and risk of loss has passed to the customer, when persuasive evidence of a sales arrangement exists, the selling price is fixed and determinable and collectability is reasonable assured.
	Accounts receivables consist of amounts due from customers and are recorded upon the shipment of product to customers. Credit terms are extended to customers in the normal course of business and no collateral is required. The Company estimates an allowance for doubtful accounts based on historical losses, the existing economic conditions and the financial stability of its customers. Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded when received.
	Inventory
	Inventory is stated at the lower of cost or market value. Cost is determined using the weighted average method, which under the circumstances, management believes will provide for the most practical basis for the measurement of periodic income. Management periodically reviews inventory for slow moving or obsolete items and considers realizability based on the Company’s marketing strategies and sales forecasts to determine if an allowance is necessary. If market value is below cost then an allowance is created to adjust the inventory carrying amount to reflect this.
	Equipment
	E equipment is recorded at cost. Equipment is depreciated using the straight-line method over the estimated useful lives.
	The estimated useful lives for each asset group are as follows:
			Years
	Furniture and equipment		4
	Computer equipment		2
	At the time depreciable property is retired or otherwise disposed of the related cost and accumulated depreciation is removed from the accounts and any resulting gain or loss is reflected in the consolidated statement of operations.
	Intangible Assets
	Indefinite-life intangible assets, consisting of costs to acquire trademarks with an indefinite life, are recorded at cost, net of impairment charges, if applicable. No amortization has been taken on indefinite life intangible assets. Indefinite-life intangible assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
	Website Costs
	The Company recognizes the costs associated with developing a website in accordance with ASC Topic 350–40. Relating to website development costs, the Company follows the guidance pursuant to ASC Topic 350–50.
	Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Internal and external costs incurred to develop internal–use computer software during the application development stage are capitalized. Training costs are not internal–use software development costs and, if incurred during this stage, are expensed as incurred.
	These capitalized costs are amortized based on their estimated useful life over two years.
	Impairment of Long-Lived Assets
	The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the related carry amounts may not be recoverable. Such a review involves assessing qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that a long-lived asset is impaired.
	If the Company assesses that there is a likelihood of impairment, then the Company will perform a quantitative analysis comparing the carrying value of the assets with the estimated future net undiscounted cash flows expected to result from the use of the assets, including cash flows from disposition. Should the sum of the expected future net cash flows be less than the carrying value, the Company would recognize an impairment loss at that date for the amount by which the carrying amount of the asset exceeds its fair value. Management has determined that no impairment currently exists.
	Shipping and Handling Costs
	Costs associated with the Company’s third-party shipping, warehousing and handling activities are included within operating expenses on the income statement.
		(i)	Shipping costs associated with marketing related promotions are included as a component of general and administrative expenses as office and miscellaneous expense. These shipping costs were $41,696 for the year ended January 31, 2014 ($36,142 for the year ended January 31, 2013).
		(ii)	Shipping costs billed to customers are recorded as revenues and related out-bound shipping costs incurred by the Company are recorded as cost of sales.
		(iii)	Warehousing and handling costs, and shipping costs associated with transfers of inventory to and from third party warehouses to the Company’s warehouse are included in general and administrative expense as warehouse management. These warehousing, shipping and handling costs were $104,580 for the year ended January 31, 2014 ($45,452 for the year ended January 31, 2013).
	Advertising Expense
	The Company expenses advertising costs to operations during the year in which they were incurred. The Company expensed $60,011 and $68,122 related to advertising for the years ended January 31, 2014 and 2013, respectively.
	Income Taxes
	The current income tax represents the amount of income taxes expected to be paid or the benefit expected to be received for the current year taxable income or loss. Deferred income taxes are recognized for the future tax consequences of temporary differences arising between the carrying value of assets and liabilities for financial statement and tax reporting purposes. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
	In assessing the recoverability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which those temporary differences become deductible. Management considers projected future taxable income and tax planning strategies in making this assessment.
	The Company recognizes the impact of a tax position in the consolidated financial statements if the position is more likely than not to be sustained upon examination on the technical merits of the position. The Company’s policy is to recognize interest accrued related to unrecognized tax benefits and penalties as income tax expense. The Company has no uncertain tax positions as of January 31, 2014 and 2013, respectively; consequently no interest or penalties have been accrued by the Company.
	Fair Value of Financial Instruments
	The Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, Fair Value Measurements and Disclosures . ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value hierarchy contains three levels of inputs that may be used to measure fair value as follows:
	Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities;
	Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals;
	Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity’s own assumptions, as there is little, if any, related market activity.
	In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.
	The Company’s financial instruments consist of cash, accounts receivable, accounts payable, notes payable, related party payables and convertible promissory notes. Other than convertible promissory notes, the fair values of these financial instruments approximate their respective carrying values because of the short maturity of these instruments. The Company determined that the aggregate fair value of notes payable outstanding at January 31, 2014, based on Level 2 inputs in the fair value hierarch, was equal to their aggregate book value based on the short maturities and current borrowing rates available to the Company.
	The fair value of the Company’s convertible promissory notes is based on Level 3 inputs in the fair value hierarchy. The Company calculated the fair value of these notes by discounting future cash flows using rates representative of current borrowing rates for debt instruments without a conversion feature and by using the Black Scholes option pricing model to determine the fair value of the conversion feature using the following assumptions:
			2014	2013
		Risk-free interest rate	0.05%	0.21%
		Expected life (years)	0.36	1.54
		Expected volatility (1)	212.64%	219.86%
		Stock price	$0.08	$0.25
		Dividend yields	0.00%	0.00%
(1) Where the Company has insufficient historical data on which to estimate expected future share price volatility, the Company has estimated expected share price volatility based on the historical share price volatility of comparable entities.
The Company determined that the fair value of the convertible promissory notes at January 31, 2014 was $1,209,300 (2013: $596,000) based on a market interest rate of 18%.
Derivative Financial Instruments
The Company evaluates its convertible debt and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815 Derivatives and Hedging. These derivatives may be included in these contracts to provide favourable terms to induce investment into the Company while preserving cash flows. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair value is recorded in the consolidated statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.
The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date.
The Company uses the binomial option pricing model to value derivative liabilities. This model uses Level 3 inputs in the fair value hierarchy established by ASC 820 Fair Value Measurement
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.
Actual results could materially differ from those estimates. The most significant estimates made by the Company are those relating to uncollectible receivables, inventory valuation and obsolescence, and product returns.
Loss per share
Earnings or loss per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted EPS is computed by dividing net income (loss) by the weighted-average of all potentially dilutive shares of common stock that were outstanding during the periods presented.
The treasury stock method is used in calculating diluted EPS for potentially dilutive stock options and share purchase warrants, which assumes that any proceeds received from the exercise of in-the-money stock options and share purchase warrants, would be used to purchase common shares at the average market price for the period.
EPS for convertible debt is calculated under the “if-converted” method. Under the if converted method, EPS is calculated as the more dilutive of EPS (i) including all interest (both cash interest and non-cash discount amortization) and excluding all shares underlying the Notes or; (ii) excluding all interest and costs directly related to the convertible debt (both cash interest and non-cash discount amortization) and including all shares underlying the convertible debt. For the years ended January 31, 2014 and 2013, diluted EPS was calculated by including interest expense related to the convertible debt and excluding the shares underlying the convertible debt.
Net loss per share was determined as follows:
		2013			2012
Numerator
Net loss	$	(4,238,490	)	$	(1,332,996	)
Less: Shareholder dividend – Note 14(i)		(239,680	)		-
	$	(4,478,170	)	$	(1,332,996	)
Denominator
Weighted average common shares outstanding		31,418,517			20,363,483
Basic and diluted net loss per share	$	(0.14	)	$	(0.07	)
Anti-dilutive securities not included in diluted
loss per share relating to:
Warrants and options outstanding		6,775,446			4,047,506
Convertible debt		9,651,379			666,667
		16,426,825			4,714,173
Accounting for Stock-Based Compensation
ASC Topic 718, Compensation – Stock Compensation , requires that compensation expense for employee stock-based compensation be recognized over the requisite service period based on the fair value of the award, at the date of grant.
The Company accounts for the granting of equity based awards to employees using the fair value method whereby all awards to employees will be recorded at fair value on the date of the grant. The fair value of all equity based awards is expensed over their vesting period with a corresponding increase to additional paid in capital. The fair value of equity based awards is estimated using the most recent share offering of the same or similar share classes (approximate market value). Compensation costs for stock-based payments to employees with graded vesting are recognized on a straight-line basis.
Based on guidance in ASC 505-50, stock-based payments to non-employees are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The fair value of stock-based payments to non-employees is periodically re-measured until the counterparty performance is complete, and any change therein is recognized over the vesting period of the award. Compensation costs for stock-based payments with graded vesting are recognized on a straight-line basis. The cost of the stock-based payments to non-employees that are fully vested and non-forfeitable as at the grant date are measured and recognized at that date, unless there is a contractual term for services in which case such compensation would be amortized over the contractual term.
New Accounting Pronouncements
There are no new accounting pronouncements that the Company recently adopted or are pending the Company’s adoption that are expected to have a material impact on the Company’s results of operations, financial position or cash flows.

Reverse_Acquisition

Reverse Acquisition	12 Months Ended
	Jan. 31, 2014
Reverse Acquisition [Text Block]	'
	4.        Reverse Acquisition
	On July 30, 2012, the Company closed the Acquisition pursuant to an Acquisition Agreement with Naked and SBH Acquisition Corp., the Company’s former subsidiary, whereby the Company acquired 100% of the issued and outstanding shares of Naked in exchange for 13,500,000 shares of common stock of the Company. Concurrent with the closing, 100,000 share purchase warrants outstanding, exercisable into 100,000 shares of common stock of Naked at $0.75 per share, were converted into warrants entitling the holders to purchase 214,506 shares of the Company’s common stock at an exercise price of $0.75 per share until July 30, 2014. The Company recorded an incremental value of $20,000 to general and administrative expenses as a result of this modification.
	To facilitate the Acquisition, Naked agreed to: (i) continue from the federal jurisdiction of Canada to the jurisdiction of the State of Nevada and (ii) merge with the Company’s subsidiary, SBH Acquisition Corp., with Naked remaining as the surviving corporation. The continuation of Naked from Canada to the State of Nevada was completed on July 27, 2012 and the merger of Naked and SBH Acquisition Corp., with Naked as the surviving corporation, was completed on July 30, 2012. As a result of the foregoing, Naked became a wholly-owned subsidiary of the Company.
	As the former stockholders of Naked now control 50% of the issued and voting shares of the Company and former management of Naked comprise more than 50% of the Board of Directors of the Company, the transaction was accounted for as a reverse acquisition and recapitalization of Naked. As Naked is deemed to be the acquirer for accounting purposes, its assets and liabilities are included in the consolidated balance sheet for the continuing entity at their historical carrying values and these consolidated financial statements are presented as a continuation of Naked.
	The Company’s assets, liabilities and results of operations have been included in these consolidated financial statements from July 30, 2012, the date of the Acquisition.
	For accounting purposes, the transaction is reflected as a recapitalization of Naked and consideration for the Acquisition was deemed to be the book value of the net assets of the Company acquired on July 30, 2012, which approximates their fair values. The net identifiable assets of the Company at the date of the Acquisition were as follows:
	Cash & receivable	$	386,790
	Accounts payable and advances payable		(108,789	)
	Due to a related party		(44,843	)
	Net assets acquired	$	233,158
	The carrying value of the net assets acquired was credited to the share capital of the combined entity. $375,000 in advances made to Naked in conjunction with the Acquisition, plus $8,133 in accrued interest, was debited against net assets as this was included in the portion of proceeds. In addition, acquisition costs of $34,951 paid were recorded as a charge against the equity of Naked balance sheets for the continuing entity at their historical carrying values and these consolidated financial statements are presented as a continuation of Naked.

Accounts_Receivable

Accounts Receivable	12 Months Ended
	Jan. 31, 2014
Accounts Receivable [Text Block]	'
	5.        Accounts Receivable
	On October 6 2011, the Company entered into a factoring agreement with Liquid Capital Exchange Corp (“the factor”) whereby it sells select accounts receivable with recourse. The factor purchases eligible accounts receivable at a discount of 3.75% and is further discounted by 1/8 of 1% if the number of days elapsed from the date of purchase of the receivable exceeds 28 days. The Company bears the risk of credit loss on the receivables at all times. These receivables are accounted for as a secured borrowing arrangement and not as a sale of financial assets.
	Under the terms of the agreement, the factor may make advances to the Company of amounts representing up to 80% of the net amount of eligible accounts receivable. The factor facility was collateralized by a general security agreement over all the Company’s personal property and interests.
	On July 26, 2012, the Company terminated the factoring agreement and bought back all amounts outstanding under the factoring agreement. An amount of $31,555 has been presented as a financing activity in the consolidated statement of cash flow during the year ended January 31, 2013. Also, during the year ended January 31, 2013, the Company recorded $6,395 in finance charges related to factor expense under the terms of this agreement. Pursuant to the termination of the factoring agreement, the Company was released from the corresponding general security agreement.
	As of January 31, 2014 and 2013, the amount of the factored receivables was $Nil,.

Inventory

Inventory	12 Months Ended
	Jan. 31, 2014
Inventory [Text Block]	'
	6.        Inventory
	Inventory of the Company consisted of the following at January 31, 2014 and 2013:
	January 31,		2014		2013
	Finished goods - Underwear	$	528,461	$	115,709
	Raw materials		75,585		120,441
	Total inventory	$	604,046	$	236,150
	Balances at January 31, 2014 and 2013 are recorded at historical cost, less amounts for potential declines in value. During the year ended January 31, 2014, management recorded write-downs of $18,322 (2013: $Nil) to reduce inventory to its net realizable value.

Equipment

Equipment	12 Months Ended
	Jan. 31, 2014
Equipment [Text Block]	'
	7.        Equipment
	Property and equipment of the Company consisted of the following at January 31, 2014 and 2013:
	January 31,		2014			2013
	Furniture & equipment	$	6,630		$	1,380
	Computer equipment		4,534			3,554
	Less: Accumulated depreciation		(4,864	)		(3,092	)
		$	6,300		$	1,842
	Depreciation expense for the years ended January 31, 2014 and 2013 was $1,694 and $1,962, respectively.

Intangible_Assets

Intangible Assets	12 Months Ended
	Jan. 31, 2014
Intangible Assets [Text Block]	'
	8.        Intangible Assets
	Intangible assets of the Company consisted of the following at January 31, 2014 and 2013:
								Useful life
			2014			2013		(Years)
	Trade Names/Trademarks	$	24,874		$	23,212		Indefinite
	Website		44,512			40,657		2
			69,386			63,869
	Less: accumulated amortization		(29,509	)		(8,455	)
		$	39,877		$	55,414
	Amortization expense for each of the years ended January 31, 2014 and 2013 was $21,054 and $9,723, respectively.

Related_Party_Payables

Related Party Payables	12 Months Ended
	Jan. 31, 2014
Related Party Payables [Text Block]	'
	9.        Related Party Payables
	At January 31, 2013, the Company had advances from shareholders in the amount of $13,916. All shareholder advances were unsecured and payable on demand. At January 31, 2014, all advances from shareholders had been repaid. The table below summarizes the balance and interest rate of each advance at January 31, 2014 and 2013:
	January 31,		2014		2013
	Advance, bearing interest at 19.50% per annum	$	-	$	9,603
	Advance, non-interest bearing		-		4,313
			-		13,916
	Less: current portion		-		(13,916	)
		$	-	$	-
	During the years ended January 31, 2014 and 2013, the Company incurred interest expense on the shareholder advances of $Nil and $1,309, respectively.
	At January 31, 2014, included in advances receivable is an amount of $50,000 (2013:$Nil) paid to a director of the Company as an advance for expenses to be incurred on behalf of the Company in the January, 2015 fiscal year. At January 31, 2014, included in accounts payable and accrued liabilities is $24,682 (2013: $Nil) owing to directors and officers of the Company for reimbursable expenses and for unpaid directors fees. These amounts are unsecured, non-interest bearing with no specific terms of repayment.

Promissory_Notes_Payable

Promissory Notes Payable	12 Months Ended
	Jan. 31, 2014
Promissory Notes Payable [Text Block]	'
	10. Promissory Notes Payable
			2014			2013
	Promissory note bearing interest at 10% per annum payable at maturity, unsecured, maturing on February 1, 2014(i)	$	75,000		$	-
	Promissory note in the principal amount of $309,062, non- interest bearing, unsecured, repayable in five equal semi- monthly instalments of $41,667 plus one final balloon payment of $63,229 at its maturity on July 13, 2014. The one-time interest charge of 15% or $37,500 is convertible at maturity, at the option of the holder, into shares of common stock of the Company at a price of $0.10 per share (iii)		309,062
						-
	Promissory note in the principal amount of CDN$16,250, non-interest bearing, repayable in equal instalments of CDN$3,125 over the remaining term of the note, unsecured. The note may be repaid at any time before maturity without notice, bonus or penalty. The final CDN$3,750, representing a 15% original issue discount (“OID”) is repayable upon the company reporting net income from operations in a single month (iv)		14,668			-
	Promissory note in the principal amount of CDN$47,917, non-interest bearing, repayable in equal instalments of CDN$9,583 over the remaining term of the note, unsecured. The note may be repaid at any time before maturity without notice, bonus or penalty (v)		43,250			-
	Less: debt discounts		(44,558	)		-
			397,422			-
	Less: current portion		(397,422	)		-
		$	-		$	-
		(i)	During the year ended January 31, 2014, the Company received $75,000 in respect of a promissory note in the principal amount of $75,000. The promissory note matures on February 1, 2014 and bears interest at a rate of 10% per annum payable at maturity. During the year ended January 31, 2014, the Company recorded $3,750 (2013: $Nil) in respect of interest on this note.
			Subsequent to January 31, 2014, the Company entered into a debt settlement agreement with this lender, pursuant to which the Company agreed to issue 796,850 common shares of the Company in full and final settlement of this note, along with accrued interest of $4,850.
		(ii)	On September 4, 2013, the Company issued a promissory note in the amount of $172,500 (the “September 4 Note”). The purchase price for this note was $150,000. The note matured on January 6, 2014 and was repayable in eight equal instalments of $21,563 over the term of the note (each a “Regular Repayment”).
			As additional consideration for entering into the note, the Company issued 100,000 common shares to the lender. The fair value at issuance of these shares of $64,000, determined with reference to the quoted market price of these shares at the date of issuance, together with an original issue discount (“OID”) of $22,500 resulted in a debt discount at issuance of $86,500, was amortized using the effective interest method over the term of the note.
			In addition, the lender was entitled to 5,000 common shares in the event the Company did not make a Regular Repayment when due and payable under the terms of the note. During the year ended January 31, 2014, the Company requested an extension on the seventh Regular Repayment and, consequently the lender was issued 5,000 common shares. The fair value of these shares of $800, which was determined with reference to the quoted market price of the Company’s stock on the commitment date, was recorded as a charge to general and administrative expense in the consolidated statement of operations for the year ended January 31, 2014.
			During the year ended January 31, 2014, the Company recorded accretion expense of $86,500 (2013: $Nil) in respect of the accretion of the discount on this note.
			On January 13, 2014, the eighth and final Regular Repayment due under the terms of this note was repaid through the issuance of a new promissory note to the same lender.
		(iii)	On January 13, 2014, the Company issued a promissory note in the principal amount of $309,062, which was comprised of: (i) $250,000 consideration received; (ii) a one-time interest charge of $37,500, being 15% of the proceeds received (the “OID”); and (iii) an amount of $21,562, being the remaining principal balance due on the September 4 Note.
			The promissory note is repayable in five monthly instalments of $41,667 over the term of the note plus one final balloon payment of $63,229 at its maturity on July 13, 2014. The Company may repay the promissory note at any time before maturity without notice, bonus or penalty.
			The OID is convertible, at the option of the lender, at maturity of the note into shares of common stock of the Company at a price of $0.10 per share.
			The issuance of this promissory note as consideration of the remaining balance due and payable under the September 4 Note was recorded at the redemption amount pursuant to the applicable guidance under ASC 470-20.
		(iv)	On November 7, 2013, the Company issued a promissory note in the principal amount of CDN$28,750. The Company received 24,467 (CDN$25,000) in respect of this note, after an original issue discount (“OID”) of 15%, or $3,670 (CDN$3,750). The note matures eight months from the date of issuance and is repayable in eight equal monthly instalments over the term of the note. The OID is repayable upon the Company recognizing net income from operations in any given month during the term of the note.
			As additional consideration for entering into the loan, the Company issued 22,000 common shares of the Company to the lender. The fair value at issuance of these shares of $5,720, determined with reference to the quoted market price of these shares at the date of issuance, together with the OID of $3,670 resulted in a debt discount at issuance of $9,390, which is being amortized using the effective interest method over the term of the note.
			During the year ended January 31, 2014, the Company recorded accretion expense of $6,110 (2013: $Nil) in respect of the accretion of the discount on this note.
		(v)	On December 20, 2013, the Company issued a promissory note in the principal amount of CDN$57,500. The Company received $47,660 (CDN$50,000) in respect of this note, after an original issue discount (“OID”) of 15%, or $7,149 (CDN$7,500). The note matures six months from the date of issuance and is repayable in six equal monthly instalments over the term of the note.
			As additional consideration for entering into the loan, the Company issued 25,000 common shares of the Company to the lender. The fair value at issuance of these shares of $3,000, determined with reference to the quoted market price of these shares at the date of issuance, together with the OID of $7,149 resulted in a debt discount at issuance of $10,149, which is being amortized using the effective interest method over the term of the note.
			During the year ended January 31, 2014, the Company recorded accretion expense of $2,164 (2013: $Nil) in respect of the accretion of the discount on this note.

Convertible_Promissory_Notes

Convertible Promissory Notes	12 Months Ended
	Jan. 31, 2014
Convertible Promissory Notes [Text Block]	'
	11.       Convertible Promissory Notes Payable
			2014			2013
	Revolving Credit Facility, bearing interest at 12% per annum, due August 16, 2014(i)	$	500,000		$	500,000
	Revolving Credit Facility, bearing interest at 12% per annum, due January 31, 2014(i)		275,000			-
	Convertible promissory note payable, non-interest bearing, due February 9, 2014(ii)		128,704			-
	Convertible promissory note payable, non-interest bearing, due November 13, 2014(iv) (Note 12)		124,444			-
	Convertible promissory notes, bearing interest at 8% per annum, due September 23, 2014 (v)		91,688			-
	Convertible promissory notes, bearing interest at 8% per annum, due September 17, 2014 (vi)		84,085			-
	Less: debt discounts		(179,957	)		(16,050	)
			1,023,964			483,950
	Less: current portion		(1,022,294	)		(483,950	)
		$	1,670		$	-
	(i)	Revolving Credit Facilities with Kalamalka Partners
		August, 2012 Credit Facility
		On August 10, 2012, the Company and its wholly owned subsidiary, Naked, entered into the Agency Agreement with Kalamalka and certain lenders (the “Lenders”) as set out in the Agency Agreement whereby the Company agreed to borrow up to $800,000 from the Lenders under a revolving loan arrangement by the issuance of convertible promissory notes (the “Notes”) from time to time as such funds are required by the Company.
		In connection with the closing of the Agency Agreement, the Company issued four convertible promissory notes in the aggregate principal amount of $400,000 (the “Closing Notes”) and an aggregate of 100,000 share purchase warrants to the Lenders (the “Lender Warrants”) exercisable into one common share of the Company as follows: 25,000 Lender Warrants exercisable at $0.25 until August 10, 2015, 25,000 Lender Warrants exercisable at $0.50 until August 10, 2015 and 50,000 Lender Warrants exercisable at $0.25 until August 10, 2014.
		On December 21, 2012, the Company issued additional Notes in the principal amounts totaling $100,000. No additional lender warrants were issued in connection with this subsequent funding.
		The Notes bear interest at 12% per annum, calculated and payable monthly. The principal amount outstanding under any Note and all accrued and unpaid interest therein, were initially convertible into common shares of the Company at $0.75 per share at any time at the option of the Lender. These terms were later amended, as set forth below.
	The Notes are collateralized by a first priority general security agreement over the present and future assets of the Company.
	The Notes may be prepaid at any time at the option of the Company with 60 days’ written notice to Kalamalka (the “Agent”) under the Agency Agreement. Prepayments must be accompanied by a 1% prepayment fee and the prepaid amount will form a pool of stand-by funds that will continue to accrue interest at a rate of 4% per annum, calculated and payable monthly.
	Pursuant to the guidance of ASC 470-20 Debt with Conversion and Other Options, the Company allocated the proceeds from the issuance of the Closing Notes between the Closing Notes and the detachable Lender warrants using the relative fair value method. The fair value of the Lender Warrants of $22,100 at issuance resulted in a debt discount at issuance of $20,940, which is being amortized using the effective interest method over the term of the Notes. During the year ended January 31, 2014, the Company recorded accretion expense of $10,462 (2013: $4,890) in respect of the accretion of this discount and $59,618 (2013: $23,208), in interest in respect of these Notes.
	In consideration for the convertible debt issued, the Company issued an aggregate of 1,148,000 share purchase warrants to non-lenders as follows: (i) 948,000 share purchase warrants to the Agent as consideration for facilitating the loan (the “Agent’s Warrants”), of which 448,000 were exercisable into common shares of the Company at $0.25 per share for a period of two years and 500,000 were exercisable into common shares of the Company at $0.50 per share for a period of two years; and (ii) 200,000 share purchase warrants to certain non-lenders as consideration for a $200,000 bridge loan provided to the Company prior to the closing of the Agency Agreement (the “Bridge Loan Warrants”), of which 125,000 Bridge Loan Warrants were exercisable into common shares of the Company at $0.25 per share for a period of three years and 75,000 Bridge Loan Warrants were exercisable into common shares of the Company at $0.50 per share for a period of three years. The fair value of the Agent’s Warrants and the Bridge Loan Warrants of $237,500 was recorded as a deferred financing charge and is being amortized to income over the term of the Notes using the effective interest method. During the year ended January 31, 2014, the Company had recorded financing expense of $99,694 (2013: $38,962) in respect of the amortization of these charges. Accumulated amortization as at January 31, 2014 was $138,656 (2013: $38,962).
	Of the total Agent’s Warrants, 900,000 warrants are transferrable by the Agent and may be transferred by the Agent to certain lenders in accordance with additional funds received under the Agreement. As the amounts transferred to lenders subsequent to the closing of the Agreement are at the sole discretion of the Agent, the Company has included these warrants as a deferred financing fee which is being amortized over the term of the Agreement, and not as a discount on additional convertible notes as they are issued.
	The fair value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants at issuance was determined using the Black Scholes option pricing model with the following weighted average assumptions:
	Risk-free interest rate	0.29%
	Expected life (years)	2.2
	Expected volatility (1)	201.94%
	Estimated stock price at date of issuance (2)	$0.25
	Dividend yields	0.00%
	(1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities.
	(2) The estimated stock price of $0.25 per share was determined with reference to the subscription price of the most recent share offerings for which the funds raised were being used to provide financing to the Company. This was considered to be the most appropriate basis on which to estimate the fair value of the Company’s stock as, at the time of the transaction, the Company’s stock was not being traded on an active market.
	Funds advanced under the loan were restricted for inventory and accounts receivable whereby we could fund up to 90% of the Company’s accounts receivable and inventory (the “Borrowing Margin Requirements”). “Inventory” includes raw materials in transit and in our possession, materials in the course of production, work in progress and unsold finished goods, all valued at cost. Receivables were marginable until 60 days from the invoice date, after which time such receivables had no value for margining purposes, except that up to $10,000 of receivables were marginable if such receivables were more than 60 days old but less than 90 days old.
	During the year ended January 31, 2013, the Company’s borrowing exceeded the required margins and these Notes entered into default. As a result, on July 22, 2013, the Company entered into an Amendment Agreement with Kalamalka and the Lenders. Pursuant to the Amendment Agreement, the Company amended the Notes to reduce the conversion price from $0.75 to $0.50 per share and amended the terms of the Lender Warrants, Bridge Loan Warrants and Agent’s Warrants such that the expiry of all of the warrants was extended by three years. In addition, the Amendment Agreement reduced the total commitment of the revolving loan facility from $800,000 to the $500,000 already advanced.
	The amendments were considered a substantial change in the terms of the loan facility and, accordingly, the Company applied debt extinguishment accounting and calculated a loss on extinguishment of debt of $485,704 as the premium of the aggregate fair value of the amended notes of $778,553 over their carrying values of $488,849 immediately prior to the amendments, plus the fair value of the modification of the Lender Warrants, Bridge Loan Warrants and Agent’s Warrants. The Company calculated the fair value of the amended convertible promissory notes by discounting future cash flows using rates representative of current borrowing rates for debt instruments without a conversion feature and by using the Black Scholes option pricing model to determine the fair value of the conversion features, using the following assumptions:
	Risk-free interest rate	0.10%
	Expected life (years)	1.07
	Expected volatility (1)	151.47%
	Stock price	$0.52
	Dividend yields	0.00%
	The fair value of the modification of the Lender Warrants, Bridge Loan Warrants and Agent’s Warrants of $196,000 was determined as the difference between the fair value of these warrants immediately prior to the amendments and the fair value of these warrants immediately after the amendment. The fair values were determined using the Black Scholes option pricing model with the following weighted average assumptions:
	Risk-free interest rate	1.03%
	Expected life (years)	4.25
	Expected volatility (1)	249.92%
	Stock price at date of issuance	$0.52
	Dividend yields	0.00%
		-1	As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities.
	The loss was recorded on the consolidated statement of operations during the year ended January 31, 2014, with a corresponding credit to additional paid in capital. In connection with the reduction in borrowing capacity, the Company wrote off $56,555 of unamortized deferred finance charges in proportion to the decrease in the borrowing capacity, and incurred $2,520 in deferred financing fees in connection with the amendments. This cost was recognized as finance charges on the consolidated statement of operations during the year ended January 31, 2014.
	Subsequent to January 31, 2014, the Company entered into an Amendment Agreement dated April 4, 2014 (the “First Kalamalka Amendment Agreement”) with Kalamalka and certain of the Lenders as set out in the Amendment Agreement (collectively, the “First Tranche Lenders”) amending the Agency and Interlender Agreement dated August 10, 2012 (the “First Agency Agreement”). In connection with the First Agency Agreement, the Company amended several of the Notes in the aggregate principal amount of $400,000 (the “First Tranche Kalamalka Notes”) as follows; (i) the Company extended the due date of the First Tranche Kalamalka Notes to October 1, 2016; (ii) the Company reduced the interest rate accruing under the First Tranche Kalamalka Notes to 6% per annum, calculated and payable quarterly, in cash or in kind; (iv) the Company removed the Borrowing Margin Requirements; (iii) the Company amended the First Tranche Kalamalka Notes to reduce the conversion price from $0.50 per share to $0.25 per share; and (v) 500,000 share purchase warrants exercisable at a price of $0.50 until August 10, 2018 held by Kalamalka were exchanged for 600,000 New Warrants, as defined and described below.
	As consideration for facilitating such amendments, the Company granted 1,200,000 share purchase warrants to the First Tranche Lenders and Kalamalka (the “New Warrants”).
	Each New Warrant is exercisable into one common share at a price of $0.15 per share until April 4, 2019. The Company has the right to call the New Warrants if the volume weighted average closing price of the Company’s shares exceeds $0.30 per share for more than 20 consecutive trading days following the closing date. In that event, the New Warrants will expire 30 days following the date the Company delivers notice in writing to the warrant holders announcing the call of the New Warrants. In addition, the New Warrants contain piggyback registration rights on any subsequent registration statement filed with the Securities and Exchange Commission (the “SEC”), including, without limitation, any registration statement that may be required to be filed with the SEC in connection with the Subsequent Financing (Note 18).
	Also in connection with the First Kalamalka Amendment Agreement, one First Tranche Lender was granted the right to exchange 100,000 share purchase warrants exercisable at a price of $0.50 until August 10, 2018 for 100,000 New Warrants.
	Also subsequent to January 31, 2014, pursuant to a Conversion Agreement dated April 4, 2014, the remaining Notes in the aggregate principal amount of $100,000 plus $1,868 in accrued interest therein were settled by the issuance of 1,018,685 common shares of the Company at a conversion price of $0.10 per share.
	November, 2013 Credit Facility
	On November 14, 2013, the Company entered into an Agency and Interlender Agreement dated November 14, 2013 (the “Agency Agreement”) with Kalamalka, and certain lenders as set out in the Agency Agreement (the “Lenders”), whereby the Company agreed to borrow up to $300,000 from the Lenders from time to time (the “Loan”). In connection with the closing of the Agency Agreement, the Company issued: (i) two convertible promissory notes (collectively, the “Notes”) in the aggregate principal amount of $100,000 and (ii) an aggregate of 125,000 share purchase warrants (each, a “Lender Warrant”) to the Lenders. On November 26, 2013, the Company issued (i) additional Notes in the principal amounts totaling $100,000 and (ii) 125,000 additional Lender Warrants and on December 24, 2013 the Company issued (i) an additional Note in the principal amount of $75,000 and (ii) 115,000 additional Lender Warrants.
	Each Lender Warrant is exercisable into one Share at a price of $0.10 per Share for a period of two years from the date of issuance.
	Each Note was due on January 31, 2014 (the “Due Date”) and bears interest at the rate of 12% per annum, calculated daily and payable on the Due Date. The principal amount outstanding under any Note, and all accrued but unpaid interest thereon, may be converted into shares of common stock of the Company at a price of $0.25 per share at any time at the option of the respective Lender. Repayment of the Notes is secured by general security agreements dated November 14, 2013, as amended and restated, made by each of the Company and its wholly owned subsidiary in favour of Kalamalka, as agent for the Lenders.
	As consideration for facilitating the Loans, the Company issued an aggregate of 362,500 warrants (the “Kalamalka Warrants”) to Kalamalka, each Kalamalka Warrant exercisable into Shares at a price of $0.10 per Share for two years from the date of issuance.
	Pursuant to the guidance of ASC 470-20 Debt with Conversion and Other Options, the Company allocated the proceeds from the issuance of the Notes between the Notes and the detachable Lender warrants using the relative fair value method.
	The Company recorded a beneficial conversion feature in the amount of $17,600 in respect of first tranche of $100,000 issued in connection with the closing of the Agency Agreement. The beneficial conversion feature was calculated based on a comparison of the proceeds of the Notes allocated to the Notes and the fair value of the common stock at the commitment date of the Notes.
	The fair value of the Lender Warrants of $58,600 at issuance resulted in a debt discount of $41,225, and along with a beneficial conversion feature of $17,600, resulted in a total debt discount at issuance of $58,825, which was amortized using the effective interest method over the term of the Notes to January 31, 2014. During the year ended January 31, 2014, the Company recorded accretion expense of $58,825 (2013: $Nil) in respect of the accretion of this discount and $5,531 (2013: $Nil), in interest in respect of these Notes.
	The fair value of the Agent’s Warrants of $67,600 was recorded as a deferred financing charge and was amortized to income over the term of the Notes to January 31, 2014 using the effective interest method.
	The fair value of the Agents Warrants and the Lender Warrants at issuance was determined using the Black Scholes option pricing model with the following weighted average assumptions:
	Risk-free interest rate	0.63%
Expected life (years)	3
Expected volatility (1)	144.71%
Stock price at date of issuance	$0.20
Dividend yields	0.00%
(1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities.
On January 31, 2014, the Company did not repay the Notes at maturity. Subsequent to January 31, 2014; the Company entered into an Amendment Agreement dated April 4, 2014 (the “Second Kalamalka Amendment Agreement”) with Kalamalka and certain lenders as set out in the Agreement (collectively, the “Second Tranche Lenders”) amending the Agency and Interlender Agreement dated November 14, 2013 (the “Second Agency Agreement”). In connection with the Second Agency Agreement, the Company amended certain convertible term promissory notes in the aggregate principal amount of $200,000 (the “Second Tranche Notes”) as follows; (i) the Company extended the due date of the Second Tranche Notes to October 1, 2016; (ii) the Company reduced the interest rate accruing under the Second Tranche Notes to 6% per annum, calculated and payable quarterly, in cash or in kind; and (iii) the Company removed the Borrowing Margin Requirements.
As consideration for facilitating such amendments, the Company granted 600,000 New Warrants to the Second Tranche Lenders and to Kalamalka.
Repayment of the First Tranche Notes and the Second Tranche Notes is collateralized by a general security agreement dated November 14, 2013, as amended on April 4, 2014 (the “Kalamalka Security Agreement”), made by the Company in favour of Kalamalka, as agent for the First Tranche Lenders and Second Tranche Lenders, which Kalamalka Security Agreement ranks pari passu with a Security Agreement entered into subsequent to January 31, 2014 (Note 18) as evidenced by an Interlender Agreement dated April 4, 2014 between CSD Holdings LLC, as Agent for the Purchasers (see Note 18), Kalamalka, First Tranche Lenders, Second Tranche Lenders, and the Company.
	In addition, subsequent to January 31, 2014, the Company exchanged a Note with an outstanding amount of $76,388, including accrued interest of $1,388, for the issuance of a SPA Note in the same amount (Note 18).
(ii)	On October 4, 2013, the Company issued an OID (Original Issue Discount) convertible promissory note in the amount of $343,212. The purchase price for this note was $300,000. The note was to mature on February 9, 2014, and was repayable in eight equal instalments of $42,902 over the term of the note (each a “Regular Repayment”).
	The note entitles the holder, at its election, at any time on or prior to maturity, to convert all or any portion of the principal amount and any interest outstanding thereon into shares of common stock of the Company at the price of $0.25 per share.
	The amounts due under the note are collateralized by a personal guarantee of a director and officer of the Company, who also pledged 4,859,613 shares of his common stock to the lender as collateral.
	As additional consideration for entering into the note, the Company issued 200,000 common shares to the lender (the “Fee Shares”). The fair value at issuance of the Fee Shares of $48,000, determined with reference to the quoted market price of these shares at the date of issuance, was recorded as a debt discount at issuance, which is being amortized using the effective interest method over the term of the note.
	In addition, the lender is entitled to 5,000 common shares in the event the Company does not make a Regular Repayment when due and payable under the terms of the note. During the year ended January 31, 2014, the Company requested an extension on the third, fourth and fifth Regular Repayments and, consequently Company issued 15,000 common shares to the lender. The fair value of these shares of $2,100, which was determined with reference to the quoted market price of the Company’s stock on the commitment date, was recorded as a charge to general and administrative expense in the consolidated statement of operations for the year ended January 31, 2014.
	The Company granted piggyback registration rights to the lender in respect of the Fee Shares pursuant to which the Company agreed to include such Fee Shares with the next registration statement to be filed with the Securities and Exchange Commission (the “SEC”). During the year ended January 31, 2014, the Company included these Fee Shares in a registration statement filed with the SEC pursuant to a registration rights agreement (Note 13).
	During the year ended January 31, 2014, the Company recorded accretion expense of $83,458 (2013: $Nil) in respect of the accretion of this discount on this note.
	In connection with the issuance of this note, the Company incurred deferred finance fees of $53,054 as follows:
	(a)	The Company paid $2,500 and issued 10,000 common shares as a structuring fee, and paid $12,125 in legal fees and expenses incurred by the lender. The fair value of the common shares issued of $2,400, was determined with reference to the quoted market price of these shares on the commitment date of the convertible promissory note.
	(b)	In addition, the Company paid a finder’s fee of $11,429 and 120,000 share purchase warrants. The share purchase warrants are exercisable into common shares of the Company at $0.2799 per share for a period of two years from the date of issuance. The fair value of the finder’s warrants of $18,400 was determined using an option pricing model under the following assumptions:
Risk-free interest rate	0.33%
Expected life (years)	2
Expected volatility (1)	211.16%
Stock price at issuance	$0.24
Dividend yields	0.00%
(1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities.
	The deferred finance fees were recorded as a deferred finance charge and are being amortized to income over the term of the note using the effective interest method. During the year ended January 31, 2014, the Company recorded financing expense of $48,916 (2013: $Nil) in respect of the amortization of these charges. Accumulated amortization as at January 31, 2014 was $48,916 (2013: $Nil).
	Subsequent to January 31, 2014, the Company did not make the sixth, seventh and eights Regular Repayments as due and the Company was required to issue 15,000 common shares to the Lender. In addition, the Company entered into a debt settlement agreement with this lender pursuant to which the Company agreed to exchange the remaining outstanding amount of $128,704 for the issuance of a new SPA note (Note 18).
(iii)	On June 12, 2013, the Company issued a promissory note in the principal amount of up to $500,000 plus accrued and unpaid interest and any other fees. On June 13, 2013, the Company received $150,000, after a 10% OID, with the remaining balance of the promissory note payable by the lender in such amounts and at such dates as the lender may choose in its sole discretion.
	The maturity date for the promissory note was June 13, 2014. The principal sum, plus any accrued but unpaid interest thereon, of the promissory note was convertible, at any time by the lender, into shares of common stock of the Company at a price which was the lesser of $1.20 or 60% of the lowest trade price in the 25 trading days prior to the conversion (the “Conversion Price”).
	The Company was permitted to repay the promissory note at any time on or before September 11, 2013 with no interest being applied. If the Company did not repay the promissory note by that date, then a one-time interest charge of 12% would be applied to the principal sum.
	The Company repaid the promissory note in full before September 11, 2013, and no interest was applied.
	In connection with the issuance of this promissory note, the Company had agreed that the terms of the promissory note will be amended if any securities are issued, while the promissory note is outstanding, at terms more favourable to the terms contained in the promissory note, such that the more favourable terms would become part of the transaction documents of the Lender. This ratchet provision and conversion feature violated the fixed for fixed criteria resulting in the recording of a derivative financial instrument in the Company’s consolidated financial statements (Note 12).
	The Company allocated the proceeds from the issuance of the promissory note first to the derivative financial instrument, at its fair value, with the remainder being allocated to the promissory note. The fair value of the derivative financial instrument of $265,000 at issuance resulted in a debt discount at issuance of $166,667, the entire principal balance of the promissory note. The remaining derivative financial instrument value over the proceeds of the debt at issuance of $115,000 was immediately expensed on the consolidated statement of comprehensive loss as derivative expense, for the year ended January 31, 2014. This discount was being amortized using the effective interest method over the term of the promissory note.
	During the year ended January 31, 2014, the Company recorded accretion expense of $166,667 (2013: $Nil) in accretion of this discount.
(iv)	On November 13, 2013, the Company issued a promissory note in the principal amount of up to $500,000 plus accrued and unpaid interest and any other fees. On November 13, 2013, the Company received $100,000, after an OID of 10%, with the remaining balance of the note payable by the lender in such amounts and at such dates as the lender may choose in its sole discretion
	The maturity date for the note is November 13, 2015. The principal sum, plus any accrued but unpaid interest thereon, of the note may be converted, at any time by lender, into shares of common stock of the Company at a price which is the lesser of $0.265 or 60% of the lowest trade price in the 25 trading days prior to the conversion (the “Conversion Price”).
	The Company was permitted to repay the promissory note at any time on or before 90 days from November 13, 2013 with 0% interest. If the Company did not repay the promissory note within the 90 days then a one-time interest charge of 12% will be applied to the principal sum. The Company did not repay the note subsequent to January 31, 2014 and consequently, a one-time interest charge of 12% was applied to the principal balance outstanding. This one- time interest charge of $13,333 was accrued in the financial statements for the year ended January 31, 2014.
	The Company granted piggyback registration rights to the lender in connection with the next registration statement to be filed with the Securities and Exchange Commission. The Company also agreed that the terms of the note will be amended if the Company issues any securities with terms more favourable than the terms contained in the note.
	In connection with the issuance of this promissory note, the Company had agreed that the terms of the promissory note will be amended if any securities are issued, while the promissory note is outstanding, at terms more favourable to the terms contained in the promissory note, such that the more favourable terms would become part of the transaction documents of the Lender. This ratchet provision and conversion feature violated the fixed for fixed criteria resulting in the recording of a derivative financial instrument in the Company’s consolidated financial statements (Note 12).
	The Company allocated the proceeds from the issuance of the promissory note first to the derivative financial instrument, at its fair value, with the remainder being allocated to the promissory note. The fair value of the derivative financial instrument of $155,500 at issuance resulted in a debt discount at issuance of $111,111, the entire principal balance of the promissory note. The remaining derivative financial instrument value over the proceeds of the debt at issuance of $55,500 was immediately expensed on the consolidated statement of comprehensive loss as derivative expense, for the year ended January 31, 2014. This discount was being amortized using the effective interest method over the term of the promissory note.
	During the year ended January 31, 2014, the Company recorded accretion expense of $670 (2013: $Nil) in accretion of this discount.
(v)	On December 23, 2013, the Company entered into two securities purchase agreements (the “Securities Purchase Agreements”) dated December 23, 2013 with two lenders, whereby the Company issued six convertible notes, each in the aggregate principal amount of $25,000 (each, a “Note”). The first two of the Notes were paid for by the lenders in cash (the “Cash Notes”) and the third, fourth, fifth and sixth of the Notes (the “Back End Notes”) were initially be paid for by the issuance of four offsetting $25,000 secured notes receivable issued to the Company by the lenders (each, a “Offsetting Note”), provided that prior to conversion of the four Back End Notes as described below, the lenders must have paid off the applicable Offsetting Note in cash.
	The Cash Notes mature on September 23, 2014 and are accruing interest at the rate of 8% per annum. The principal sum and any accrued and unpaid interest of the Notes are convertible, at the option of the holder, at any time after 180 days after issuance, and after full cash payment for the shares convertible thereunder, at a price per share equal to 55% of the average of the two lowest closing bid prices as reported on the OTCQB for the ten prior trading days.
	The Notes may be redeemed at any time on or before 180 after issuance, subject to redemption premiums of 20-40%. The notes may not be redeemed after 180 days.
	The Cash Notes have been recorded as stock settled debt in accordance with ASC 480 whereby a put premium of $20,455 was recorded on each Cash Note and is being amortized using the effective interest method over the term of the respective Cash Note.
	The Back End Notes have been presented net of their respecting Offsetting Note as these Notes have no substance until the applicable Offsetting Note has been paid for in cash by the Lender.
	During the year ended January 31, 2014, the Company recorded accretion expense of $4,456 (2013: $Nil) in accretion of these discounts.
	In connection with the issuance of the Cash Notes, the Company incurred deferred finance fees of $8,000. The deferred finance fees were recorded as a deferred finance charge and are being amortized to income over the term of the Cash Notes using the effective interest method. During the year ended January 31, 2014, the Company recorded financing expense of $1,056 (2013: $Nil) in respect of the amortization of these charges. Accumulated amortization as at January 31, 2014 was $1,056 (2013: $Nil).
(vi)	The Company entered into a securities purchase agreement dated December 30, 2013 (the “SPA”) with a lender, whereby the Company issued a convertible note in the aggregate principal amount of $83,500.00 (the “Note”).
	The Note matures on September 17, 2014 and is accruing interest at a rate of 8% per annum. Any amount of principal or interest on the Note which is not paid when due will bear interest at the rate of 22% per annum from the due date until the same is paid.
	The principal sum and any accrued and unpaid interest of the Note is convertible, at the option of the holder, at any time after 180 days after issuance, at a price for each share equal to 61% of the average of the three lowest closing bid prices as reported on the OTCQB for the ten prior trading days.
	The Note may be redeemed at any time on or before 180 after issuance, subject to redemption premiums of 15-40%. The notes may not be redeemed after 180 days.
	In connection with the issuance of this Note, the Company had agreed that the terms of the Note will be amended if any securities are issued, while the Note is outstanding, at terms more favourable to the terms contained in the Note, such that the more favourable terms would become part of the transaction documents of the Lender. This ratchet provision and conversion feature violated the fixed for fixed criteria resulting in the recording of a derivative financial instrument in the Company’s consolidated financial statements (Note 12).
	The Company allocated the proceeds from the issuance of the Note first to the derivative financial instrument, at its fair value, with the remainder being allocated to the Note. The fair value of the derivative financial instrument of $8,376 at issuance resulted in a debt discount, which is being amortized using the effective interest method over the term of the Note.
	During the year ended January 31, 2014, the Company recorded accretion expense of $989 (2013: $Nil) in accretion of this discount.
	In connection with the issuance of the Note, the Company incurred deferred finance fees of $11,500. The deferred finance fees were recorded as a deferred finance charge and are being amortized to income over the term of the Note using the effective interest method. During the year ended January 31, 2014, the Company recorded financing expense of $1,320 (2013: $Nil) in respect of the amortization of these charges. Accumulated amortization as at January 31, 2014 was $1,320 (2013: $Nil).

Derivative_financial_instrumen

Derivative financial instruments	12 Months Ended
	Jan. 31, 2014
Derivative financial instruments [Text Block]	'
	12. Derivative financial instruments
	During the year ended January 31, 2014, the Company had derivative financial instruments associated with convertible promissory notes (Notes 11 (iii), (iv) and (vi)).
	As a result of the application of ASC 815, the Company has recorded these derivative financial instruments at their fair value as follows:
		Derivative financial instruments, January 31, 2013	$	-
		Fair values at commitment dates		428,876
		Fair value mark to market adjustments		(9,358	)
		Reclassification of fair value to additional paid-in capital upon extinguishment of host contract		(177,900	)
		Derivative financial instruments, January 31, 2014	$	241,618
	On the commitment date of the related convertible promissory notes, the Company recorded a debt discount to the extent of the gross proceeds of the promissory note, and immediately expensed the remaining derivative value as a derivative expense on the consolidated statement of comprehensive loss. During the year ended January 31, 2014, the Company recorded derivative expenses of $170,500 (2013: $Nil) in respect of the excess of the fair value of derivative financial instruments at the commitment date over consideration received under the corresponding host contracts.
	The Company determined fair value of the derivative financial instruments at January 31, 2014 and as at the commitment dates, and the extinguishment date based on the following weighted average management assumptions:
			January 31,	Extinguishment	Commitment
			2014	date	date
		Risk-free interest rate	0.34%	0.08%	0.27%
		Expected life (years)	1.78	0.76	1.73
		Expected volatility (1)	132.09%	137.74%	157.41%
		Stock price at date of issuance	$0.08	$0.53	$0.51
		Dividend yields	0.00%	0.00%	0.00%
	(1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities.
	During the year ended January 31, 2014, the Company repaid a promissory note which contained a derivative financial instrument and this derivative financial instrument was extinguished. Upon extinguishment, the fair value of the derivative financial instrument of $177,900 was recorded as a credit to additional paid in capital.

Securities_Purchase_Agreement

Securities Purchase Agreement	12 Months Ended
	Jan. 31, 2014
Securities Purchase Agreement [Text Block]	'
	13.      Securities Purchase Agreement
	On September 10, 2013, the Company entered into an $8,300,000 securities purchase agreement (the “Purchase Agreement”) with Lincoln Park Capital Fund, LLC, (“Lincoln Park”) an Illinois limited liability company (the “Financing”) pursuant to which the Company may sell and issue to Lincoln Park, and Lincoln Park is obligated to purchase, up to $8,300,000 in value of its shares of common stock from time to time over a 24 month period. In connection with the Financing, the Company also entered into a registration rights agreement with Lincoln Park whereby the Company agreed to file a registration statement with the Securities and Exchange Commission (the “SEC”) covering the shares of the Company’s common stock that may be issued to Lincoln Park under the Purchase Agreement.
	The Company will determine, at its own discretion, the timing and amount of its sales of common stock, subject to certain conditions and limitations. The purchase price of the shares that may be sold to Lincoln Park under the Purchase Agreement will be based on the market price of the Company’s shares of common stock immediately preceding the time of sale without any fixed discount, provided that in no event will such shares be sold to Lincoln Park when the closing sale price is less than $0.35 per share. There are no upper limits on the per share price that Lincoln Park may pay to purchase such common stock. The purchase price will be equitably adjusted for any reorganization, recapitalization, non-cash dividend, stock split or similar transaction occurring during the business days used to compute such price.
	Pursuant to the Purchase Agreement, Lincoln Park initially purchased 600,000 shares of the Company’s common stock for $300,000. In consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park 919,500 shares of common stock as a commitment fee and shall issue up to 330,000 shares pro rata, when and if, Lincoln Park purchases at the Company’s discretion the remaining $8,000,000 aggregate commitment. The Purchase Agreement may be terminated by the Company at any time at its discretion without any cost to the Company.
	On December 12, 2013, this registration statement was declared effective by the SEC.
	The Company incurred $58,656 in direct expenses in connection with the Purchase Agreement and registration statement. These were recorded as share issuance costs as a charge against additional paid in capital during the year ended January 31, 2014. The shares of common stock issued a commitment fee are being recorded as a share issuance cost at par value with a corresponding charge against additional paid in capital in the period they are issued.

Stockholders_Equity

Stockholders Equity	12 Months Ended
	Jan. 31, 2014
Stockholders Equity [Text Block]	'
	1 4. Stockholders’ Equity
	Equity Transactions
	Disclosure in respect of share issuances made before July 30, 2012 has not been retrospectively restated to reflect the exchange ratio of 2.14506 in relation to the reverse acquisition.
	During the year ended January 31, 2014:
	i)	On February 21, 2013, the Company reduced the price of 200,000 units and 14,000 common shares issued during the year ended January 31, 2013 from $0.50 to $0.25 per unit and share, respectively. Consequently, the Company issued 200,000 units and 14,000 common shares for no additional consideration. Each unit consisted of one common share of the Company and one share purchase warrant. Each warrant is exercisable into one share of common stock at an exercise price of $0.75 per share for a period of two years from the date of the initial offering. The Company determined that the aggregate fair value on the grant date of these units and shares was $239,680 and recorded the entire amount as a shareholder dividend in the financial statements during the three months ended October 31, 2013. The fair value of $1.12 per share was determined by reference to the quoted market price of the Company’s stock on the date of issuance.
	ii)	On April 19, 2013, the Company issued 1,993,000 shares of common stock at a price of $0.25 per share and 100,000 units of the Company at $0.25 per unit for gross proceeds of $523,250. Each unit consisted of one common share of the Company and one share purchase warrant. Each warrant is exercisable into one share of common stock at an exercise price of $0.25 per share for a period of two years. In connection with the foregoing private placement, the Company issued 104,440 warrants to four finders. Each warrant is exercisable into one share of common stock of the Company at an exercise price of $0.75 per share for a period of two years. The Company paid finder’s fees of $26,610 in connection with this private placement.
	iii)	On May 6, 2013, the Company issued 1,000,000 shares of common stock at a price of $0.25 per share for gross proceeds of $250,000 to be received in four tranches as follows:
		(i)	$50,000 payable on closing of the Financing (the “Closing”)(received);
		(ii)	$50,000 payable on or before the date which is five months from the Closing (the “First Tranche”)(received);
		(iii)	$50,000 payable on or before the date which is ten months from the Closing (the “Second Tranche”); and
		(iv)	the remaining $100,000 payable on or before the date which is one year from the Closing (the “Final Tranche”)
	In connection with the 800,000 common shares issuable in connection with the First Tranche, the Second Tranche and the Final Tranche, the Company entered into an escrow agreement pursuant to which these shares were placed in escrow to be released when the Company received full payment for such shares.
		The Company paid a finders’ fee of 20,000 warrants in connection with this private placement. These warrants are exercisable at $0.25 per share for a period of two years.
		Subsequent to January 31, 2014, the Company did not receive payment for the Second Tranche and the remaining 600,000 common shares held in escrow were returned to the Company’s treasury for cancellation.
	iv)	On June 3, 2013, the Company issued 75,000 common shares in exchange for services rendered pursuant to a consulting agreement dated April 11, 2013. The shares were recorded at a fair value of $89,250. The fair value of $1.19 per share was determined with reference to the quoted market price of the company’s common stock on the commitment date.
	v)	On October 7, 2013, the Company issued 240,000 units at a price of $0.25 per share for gross proceeds of $60,000. Each unit consisted of one common share of the Company and one share purchase warrant. Each warrant is exercisable into one share of common stock at an exercise price of $0.25 per share for a period of eighteen months.
	vi)	On November 21, 2013, the Company issued 4,304 common shares pursuant to a debt settlement agreement dated July 8, 2013, as payment to a vendor of $4,820 owing. This resulted in a gain on extinguishment of debt of $3,701. The fair value of $0.26 per share was determined with reference to the quoted market price of the Company’s stock on the date of issuance.
	vii)	On November 21, 2013, the Company issued 25,000 common shares as additional consideration to a lender under a promissory note agreement in the principal amount of $23,992 (CDN$25,000). This loan was issued and repaid during the year ended January 31, 2014. The fair value at issuance of these shares of $6,500, determined with reference to the quoted market price of these shares at the date of issuance. In connection with the issuance of this loan, the Company incurred aggregate financing fees of $10,099, which included the fair value of the shares issued.
	viii)	On January 13, 2014, the Company issued 15,000 common shares in exchange for services rendered pursuant to an investor relations agreement dated December 6, 2012. The Company determined that the fair value on the grant date of these shares was $3,750 and recorded the entire amount as compensation expense in the financial statements for the year ended January 31, 2013. The fair value of $0.25 per share was determined by reference to the price at which common shares were being sold in private placement offerings at or around the transaction date.
	ix)	On January 13, 2014, the Company issued 29,843 common shares pursuant to a consulting agreement dated February 15, 2013 (the “Consulting Agreement”), whereby the Company agreed to issue shares in exchange for services to be rendered during the term of the Consulting Agreement, to September 30, 2013. The consultant was entitled to receive a monthly fee of $4,500 payable in shares, based on the average closing price of the Company’s shares for the first month of trading commencing on the date of the Consulting Agreement. As a result, the Company issued 3,979 shares per month for the term of the agreement. During the year ended January 31, 2014, the Company recorded $2,089 (2013: $nil) in fees paid in shares pursuant to this Consulting Agreement.
	x)	On January 13, 2014, the Company issued 25,000 common shares as payment to a vendor of $15,000 owing for consulting fees rendered, pursuant to a debt settlement agreement dated July 18, 2013. This resulted in a gain on extinguishment of debt of $13,250. The fair value of $0.07 per share was determined with reference to the quoted market price of the Company’s stock on the date of issuance.
	xi)	On January 13, 2014, the Company issued 63,492 common shares as payment to a vendor for consulting fees rendered, pursuant to a debt settlement agreement dated September 18, 2013 whereby the Company has agreed to settle an aggregate of $40,000 in amounts owing to the vendor, along with cash payments totaling $20,000. The Company recorded a reduction in amounts owing to the vendor of $4,444 in connection with the issuance of the shares. The fair value of $0.07 per share was determined with reference to the quoted market price of the Company’s stock on the date of issuance.
	xii)	On January 13, 2014, the Company issued 75,000 common shares pursuant to a board agreement dated September 24, 2013, whereby the Company has agreed to issue 75,000 shares of common stock every three months over the term of the one year contract in connection with the appointment of a director of the Company, for an aggregate of 300,000 common shares over the term. During the year ended January 31, 2014, the Company recorded directors fees of $18,000 (2013: $Nil) in respect of the first 75,000 common shares that have been earned under this agreement. The fair value of $0.24 per share was determined with reference to the quoted market price of the shares on the date of issuance.
	xiii)	On January 31, 2014, the Company issued 450,000 common shares in exchange for the cancellation of an aggregate of 450,000 stock options pursuant to an Amendment Agreement dated January 6, 2014 with a director of the Company, whereby the Company agreed to amend the terms of the directors’ compensation in connection with a board agreement dated July 19, 2013. During the year ended January 31, 2014, the Company recorded directors fees of $31,200 (2013: $Nil) in respect of the issuance of these shares. The fair value of the grant was determined as the difference between the quoted market price of the shares on the date of issuance of $45,000, less the fair value of the stock options cancelled of $13,800, as exchange for their issuance. The fair value of the stock options cancelled was determined based on the Black Scholes option pricing model using the following weighted average assumptions: Estimated volatility 138.17%, stock price $0.10, risk-free interest rate 0.40%, expected term 1.53 years, estimated dividends 0%.
	During the year ended January 31, 2013:
	i)	On October 12, 2012, the Company issued 14,000 shares at $0.50 per share for gross proceeds of $7,000. Subsequent to January 31, 2013, the Company amended the subscription price for these shares to $0.25 per share and, consequently, the Company issued an additional 14,000 shares for no additional consideration.
	ii)	On September 24, 2012, the Company issued 200,000 units at $0.50 per unit for gross proceeds of $100,000. Each unit consisted of one common share of the Company and one share purchase warrant. Each warrant is exercisable into one share of common stock at an exercise price of $0.75 per share for a period of two years. Subsequent to January 31, 2013, the Company amended the subscription price for these units to $0.25 per unit and, consequently, the Company issued an additional 200,000 units for no additional consideration. Each additional unit consisted of one common share of the Company and one share purchase warrant exercisable into one share of common stock at an exercise price of $0.75 per share for a period of two years.
	iii)	On November 26, 2012, the Company issued 400,000 units at CDN$0.25 per unit for gross proceeds of $100,686 (CDN$100,000). Each unit consisted of one common share of the Company and one share purchase warrant. Each warrant is exercisable into one share of common stock at an exercise price of $0.50 per share for a period of two years. The Company paid share issuance costs of $8,055 and was required to issue 32,000 share purchase warrants as finder’s fees in connection with this issuance. The finder’s fee warrants will be exercisable into common shares of the Company at $0.75 per share for a period of two years from the date of closing. These warrants were issued subsequent to January 31, 2013.
	iv)	On November 24, 2012, the Company issued 400,000 common shares at CDN$0.25 per share for gross proceeds of $100,330 (CDN$100,000).
	v)	On December 10, 2012, the Company issued 100,000 units at $0.25 per unit for gross proceeds of $25,000. Each unit consisted of one common share of the Company and one share purchase warrant. Each warrant is exercisable into one share of common stock at an exercise price of $0.50 per share for a period of two years. The Company paid share issuance costs of $2,000 and was required to issue 8,000 share purchase warrants as finder’s fees in connection with this issuance. The finder’s fee warrants will be exercisable into common shares of the Company at $0.75 per share for a period of two years from the date of closing. These warrants were issued subsequent to January 31, 2013.
	vi)	On January 8, 2013, the Company issued 400,000 shares at $0.25 per share for gross proceeds of $100,000. There was share issuance cost of $8,000 in connection with this issuance.
	vii)	As part of the acquisition agreement with Search By Headlines.com Corp., stockholders exchanged shares of Naked for shares of common stock in the capital of the Company at a ratio of 2.145060, where Naked stockholders received a total of 13.5 million common stock in the capital of the Company (Note 4).
	viii)	On July 25, 2012, Naked awarded 147,062 Class E common shares, prior to the Acquisition, to consultants for work performed. Naked determined that the fair value on the grant date of these shares was $38,766 and recorded the entire amount as general and administration expense in the consolidated financial statements for the year ended January 31, 2013. The fair value of $0.25 per share was determined with reference to the subscription price of the most recent share offerings, for which the funds raised were being used to provide financing to the Company.
	ix)	On July 16, 2012, Naked issued 63,321 shares of Class E common stock fair valued at $15,486, in addition to $8,238 cash, to extinguish debt of $21,372. This resulted in a loss of $2,352. The fair value of $0.25 per share was determined with reference to the subscription price of the most recent share offerings, for which the funds raised were being used to provide financing to the Company.
	x)	On May 23, 2012, Naked granted 14,006 Class E common shares, prior to the Acquisition, to a director of the Company for director fees earned. Naked determined that the fair value on the grant date of these shares was $3,440 and recorded the entire amount as compensation expense in the financial statements for the year ended January 31, 2013. The fair value of $0.25 per share was determined with reference to the subscription price of the most recent share offerings, for which the funds raised were being used to provide financing to the Company.
	Stock Option Plan
	In connection with the closing of the Acquisition (Note 4), the Company adopted the 2012 Stock Option Plan (the “Plan”), pursuant to which the Company may grant stock options to directors, officers, employees and consultants. The maximum number of shares reserved for issue under the plan is 5,400,000 shares.
	The Plan is administered by the Company’s board of directors, except that it may, in its discretion, delegate such responsibility to a committee comprised of at least two directors. Each option, upon its exercise, entitles the optionee to acquire one common share of the Company’s stock, upon payment of the applicable exercise price. The exercise price will be determined by the board of directors at the time of grant. Stock options may be granted under the Plan for an exercise period of up to ten years from the date of grant of the option or such lesser periods as may be determined by the board, subject to earlier termination in accordance with the terms of the Plan.
	Stock Based Compensation
	A summary of the status of the Company’s outstanding stock options for the years ended January 31, 2014 and 2013 is presented below:
								Weighted
						Weighted		Average Grant
			Number			Average		Date
			of Options			Exercise Price		Fair Value
	Outstanding at January 31, 2012		-
	Granted		1,885,000		$	0.25	$	0.24
	Outstanding at January 31, 2013		1,885,000		$	0.25
	Granted		1,570,000		$	0.5	$	0.44
	Cancelled		(450,000	)	$	0.5
	Outstanding at January 31, 2014		3,005,000		$	0.34
	Exercisable at January 31, 2014		2,246,184		$	0.38	$	0.27
	Exercisable at January 31, 2013		668,728		$	0.25	$	0.24
	At January 31, 2014, the following stock options were outstanding, entitling the holder thereof to purchase common shares of the Company as follows:
		Exercise	Expiry	Remaining
	Number	Price	Date	Contractual Life
	285,000	$0.25	30-Jul-14	0.49
	20,000	$0.25	1-Feb-15	1
	90,000	$0.25	14-Feb-15	1.04
	15,000	$0.25	25-Jul-15	1.48
	250,000	$0.75	1-Oct-15	1.67
	15,000	$0.25	19-Dec-15	1.88
	150,000	$0.35	6-Jan-16	1.93
	150,000	$0.55	6-Jan-16	1.93
200,000	$0.75	6-Jan-16	1.93
30,000	$0.25	1-Apr-16	2.17
600,000	$0.25	9-Oct-17	3.69
50,000	$0.25	1-Feb-18	4.01
150,000	$0.25	1-May-18	4.25
1,000,000	$0.25	30-Jul-22	8.5
3,005,000
The aggregate intrinsic value of stock options outstanding is calculated as the difference between the exercise price of the underlying awards and the fair value of the Company’s common stock. At January 31, 2014, the aggregate intrinsic value of stock options outstanding is $Nil and exercisable is $Nil (2013: $Nil and $Nil, respectively).
The following table summarizes information regarding non-vested stock options outstanding during the years ended January 31, 2014 and 2013
		Number of
		Options
Non-vested options at January 31, 2012		-
Granted		1,885,000
Vested		(668,728	)
Non-vested options at January 31, 2013		1,216,272
Granted		1,570,000
Vested		(1,802,456	)
Cancelled		(225,000	)
Non-vested options at January 31, 2014		758,816
During the year ended January 31, 2014, the Company recognized a total fair value of $715,915 (2013: $218,268) of stock based compensation expense relating to the issuance of stock options in exchange for services.
The fair value of each option award was estimated on the date of the grant using the Black-Scholes option pricing model based on the following weighted average assumptions:
	2014	2013
Expected term of stock option (years) (1)	1.48	4.28
Expected volatility (2)	184.40%	260.50%
Estimated stock price at date of issuance (3)	$0.71	$0.25
Risk-free interest rate	0.18%	0.55%
Dividend yields	0.00%	0.00%
(1) As the Company has insufficient historical data on which to estimate the expected term of the options, the Company has elected to apply the short-cut method to determine the expected term under the guidance of Staff Accounting Bulletin No. 110 (“SAB 110”).
(2) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company has estimated expected share price volatility based on the historical share price volatility of comparable entities.
(3) An estimated stock price of $0.25 per share was determined with reference to the subscription for which the funds raised during the year ended January 31, 2013, were being used to provide financing to the Company. This was considered to be the most appropriate basis on which to estimate the fair value of the Company’s stock for stock options granted prior to February 15, 2013 because, at the time of these transactions, the Company’s stock was not being traded on an active market.
During the year ended January 31, 2014, the Company amended the terms of 500,000 stock options issued to a consultant of the Company as follows:
	(i)	150,000 options were re-priced from $1.25 to $0.35 ;
	(ii)	150,000 options were re-priced from $1.75 to $0.55 ;
	(iii)	200,000 options were re-priced from $2.25 to $0.75 ; and
	(iv)	The expiry of all 500,000 options was extended from June 18, 2015 to January 6, 2016.
The Company recognized stock based compensation expense of $15,700 in connection with this modification. The fair value of the modification was determined using the Black Scholes option pricing model using the following weighted average assumptions: risk-free interest rate: 0.40%, expected life: 1.72 years, expected volatility: 141.53%, dividend rate: 0.00% .
Share Purchase Warrants
At January 31, 2014, the Company had 3,770,446 share purchase warrants outstanding as follows:
	Exercise	Expiry
Number	Price	Date
24,000 *	$0.75	19-Apr-14
214,506	$0.75	30-Jul-14
400,000	$0.75	24-Sep-14
400,000	$0.50	26-Nov-14
100,000	$0.50	10-Dec-14
72,000	$0.75	31-Dec-14
240,000	$0.25	7-Apr-15
120,000	$0.25	19-Apr-15
104,440	$0.75	19-Apr-15
120,000	$0.28	4-Oct-15
498,000	$0.25	10-Aug-17
500,000	$0.50	10-Aug-17
250,000	$0.10	14-Nov-16
250,000	$0.10	26-Nov-16
227,500	$0.10	24-Dec-16
150,000	$0.25	10-Aug-18
100,000	$0.50	10-Aug-18
3,770,446
*Subsequent to January 31, 2014, these warrants expired unexercised.
A summary of the Company’s share purchase warrants outstanding is presented below:
							Weighted
		Number of					Average
		Warrants					Exercise Price
Outstanding at January 31, 2012		100,000			CADS		0.75
Cancelled		(100,000	)		CAD$		0.75
Re-issued pursuant to the Acquisition (Note 4)		214,506			USD$		0.75
Issued		1,948,000			USD$		0.44
Outstanding at January 31, 2013		2,162,506			USDS		0.47
Issued		1,609,940			USD$		0.31
Outstanding at January 31, 2014		3,770,446			USD$		0.4

Income_Taxes

Income Taxes	12 Months Ended
	Jan. 31, 2014
Income Taxes [Text Block]	'
	15.      Income Taxes
	The reconciliation of income tax provision computed at statutory rates to reported income tax provision is as follows:
	January 31,		2014			2013
			34%			34%
	Loss for the year	$	(4,238,490	)	$	(1,332,996	)
	Expected income tax recovery		(1,441,100	)		(453,200	)
	Effect of change in tax rates		-			(132,800	)
	Non-deductible expenses		394,100			84,700
	Impact of reverse acquisition and emigration on tax assets		-			300,200
	Effect of foreign exchange and other adjustments		(19,700	)		-
	Change in valuation allowance		1,066,700			201,100
	Total income tax expense	$	-		$	-
	Significant components of the Company’s net deferred tax assets at January 31, 2014 and 2013:
	January 31,		2014			2013
	Temporary differences relating to:
	Net operating loss carry forwards	$	1,049,300		$	309,800
	Incorporation costs and Intangible assets		(7,600	)		(15,100	)
	Stock based compensation		318,300			-
			1,360,500			294,700
	Valuation allowance		(1,360,500	)		(294,700	)
	Net deferred taxes	$	-		$	-
	Deferred tax assets and liabilities are determined based on temporary basis differences between assets and liabilities reported for financial reporting and tax reporting. The ultimate realization of the net deferred tax asset is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers projected future taxable income, recent financial performance and tax planning strategies in making this assessment. The Company is required to record a valuation allowance to reduce its net deferred tax asset to the amount that is more likely than not to be realized. Accounting guidance allows the Company to look to future earnings to support the realizability of the net deferred assets. Since the Company has had cumulative net operating losses since inception, the ability to use forecasted future earnings is diminished. As a result, the Company concluded a full valuation allowance against the net deferred tax asset was appropriate. At January 31, 2014 and 2013 the total change in valuation allowance was $1,066,700 and $201,100, respectively.
	At January 31, 2014, the Company had accumulated net operating losses in Canada totaling approximately $1,666,000 (2013: $528,000), which may be available to reduce taxable income in Canada in future taxation years. At January 31, 2014, the Company had accumulated net operating losses in USA totaling approximately $1,419,000 (2013: $385,000), which may be available to reduce taxable income in the United States in future taxation years. Unless previously utilized, these net operating losses will begin to expire in 2025.
	The Company files income tax returns in the United States and Canada. All of the Company’s tax returns are subject to tax examinations until the respective statute of limitations. The Company currently has no tax years under examination. The Company’s tax filings for the years 2010 to 2013 remain open to examination.
	Based on management’s assessment of ASC Topic 740 Income Taxes , the Company does not have an accrual for uncertain tax positions as of January 31, 2014 and 2013. The Company does not anticipate significant changes to its unrecognized tax benefits within the next twelve months.

Customer_Concentrations

Customer Concentrations	12 Months Ended
	Jan. 31, 2014
Customer Concentrations [Text Block]	'
	16. Customer Concentrations
	The Company has concentrations in the volumes of business transacted with particular customers. The loss of these customers could have a material adverse effect on the Company’s business.
	For the year ended January 31, 2014, the Company had concentrations of sales with a customer equal to 37.0% (2013: 55.3%) of the Company’s net sales. As at January 31, 2013 the accounts receivable balance for this customer was $15,462 (2013: $325,530).
	For the year ended January 31, 2014, the Company had concentrations of sales with another customer equal to 12.0% (2013: 22.8%) of the Company’s net sales. As at January 31, 2014 the accounts receivable balance from this customer was $3,821 (2013: Nil).

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Jan. 31, 2014
Related Party Transactions [Text Block]	'
	17.      Related Party Transactions
	During the year ended January 31, 2014, the Company recorded directors fees of $56,000 (2013: $Nil) for cash compensation paid to directors of the Company, $56,700 (2013: $Nil) in common stock compensation for shares of common stock issued to directors of the Company related to services provided as directors, and $267,918 (2013: $63,276) in stock option compensation expense related to the vesting of stock options issued the directors and officers of the Company. These amounts are included as a component of general and administrative expenses on the consolidated statement of comprehensive loss.
	On January 6, 2014, the Company entered into an Amendment Agreement with a director of the Company whereby the Company amended the terms of the director’s compensation in connection with a board agreement dated July 19, 2013. Under the terms of the Amendment Agreement, the Company issued an aggregate of 450,000 shares of common stock to the director in exchange for the cancellation of an aggregate of 450,000 stock options issued to the director in connection with his appointment as a director. See note 14 (xiii).
	During the year ended January 31, 2014, the Company issued 75,000 common shares pursuant to a board agreement dated September 24, 2013, whereby the Company has agreed to issue 75,000 shares of common stock every three months over the term of the one year contract in connection with the appointment of a director of the Company, for an aggregate of 300,000 common shares over the term. During the year ended January 31, 2014, the Company recorded directors fees of $18,000 (2013: $Nil) in respect of the first 75,000 common shares that have been earned under this agreement. At January 31, 2014, an amount of $7,500 relating to an additional 75,000 common shares issuable under the terms of this agreement were included in common stock to be issued. The fair value of $0.10 per share was determined with reference to the quoted market price of the Company’s shares on the date these shares were committed to be issued.

Subsequent_Events

Subsequent Events	12 Months Ended
	Jan. 31, 2014
Subsequent Events [Text Block]	'
	18.      Subsequent Events
	On April 7, 2014 the Company entered into a Securities Purchase Agreement (the “SPA”) with certain purchasers (the “Purchasers”), whereby the Purchasers agreed to purchase 6% senior secured convertible promissory notes (the “SPA Notes”). Repayment of the SPA Notes are secured against all the tangible and intangible assets of the Company (the “SPA Security Agreement”).
	On April 7, 2014, in connection with the SPA, the Company issued seven SPA Notes to the Purchasers, including one director of the Company, in the aggregate principal amount of $1,033,796. As consideration, the Company (i) received cash proceeds equal to $828,704 (the “Cash Proceeds”); (ii) exchanged a promissory note with an outstanding amount of $76,388, being the principal and accrued interest due under a convertible promissory note dated December 24, 2013 for the issuance of a SPA Note in the same amount; and (iii) exchanged a promissory note with an outstanding amount of $128,704, being the remaining principal amount due under a convertible promissory note dated October 2, 2013 (Note 10) for the issuance of a SPA Note in the same amount.
	The principal amount of $1,033,796 matures on April 7, 2015 (the “Maturity Date”) and bears interest at the rate of 6% per annum, payable on the Maturity Date. In addition, the principal amount of the SPA Notes and all acquired and unpaid interest thereon will be exchanged for any other securities issued by the Company in connection with any subsequent financing approved by the majority of the Purchasers which results in gross proceeds to the Company of at least $3,000,000 (the “Subsequent Financing”), at an exchange rate equal to ninety percent ( 90%) of the aggregate purchase price paid in the Subsequent Financing.
	The SPA Notes are covered by an Agency and Interlender Agreement dated April 7, 2014 between the Purchasers and CSD Holdings LLC, as agent (the “Agent”) whereby the Purchasers have appointed the Agent to act on their behalf with respect to certain rights and obligations provided for in the SPA, SPA Notes and the SPA Security Agreement.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jan. 31, 2014
Principles of Consolidation and Basis of Accounting [Policy Text Block]	'
	Principles of Consolidation and Basis of Accounting
	These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Naked. All inter-company transactions and balances were eliminated.
Reporting Currency and Foreign Currency [Policy Text Block]	'
	Reporting Currency and Foreign Currency
	The functional currency of the Company is the US dollar. Transaction amounts denominated in foreign currencies are translated into their US dollar equivalents at exchange rates prevailing at the transaction dates. Foreign currency gains and losses on transactions or settlements are recognized in the consolidated statement of operations.
	The functional currency of Naked changed from Canadian dollars to US dollars on November 1, 2012, triggered by a shift in cash flows from operations and an accumulation of other factors. Balances denominated in foreign currencies were re-measured at the date of change using the exchange rate in effect on that date. Revenue and expense items were translated at average rates for the period up to the date of change and translation adjustments accumulated in other comprehensive income up to the date of change were retained in that account.
	These financial statements have been presented in US dollars, which is the Company’s reporting currency. Prior to the change in functional currency during the year ended January 31, 2013, financial statements of foreign operations for which the functional currency is the local currency are translated into US dollars with assets and liabilities translated at the current rate on the balance sheet date and revenue and expense items translated at the average rates for the period. Translation adjustments are recorded as accumulated other comprehensive income (loss) in stockholders’ equity.
Segment Reporting [Policy Text Block]	'
	Segment Reporting
	The Company used several factors in identifying and analyzing reportable segments, including the basis of organization, such as differences in products and services, and geographical areas. Our chief operating decision makers review financial information presented on a consolidated basis for the purposes of making operating decisions and assessing financing performance. Accordingly, the Company has determined that as of January 31, 2014 and 2013, there is only a single reportable operating segment.
Revenue Recognition, Accounts Receivable and Allowance for Doubtful Accounts [Policy Text Block]	'
	Revenue Recognition, Accounts Receivable and Allowance for Doubtful Accounts
	Sales are recorded when title and risk of loss has passed to the customer, when persuasive evidence of a sales arrangement exists, the selling price is fixed and determinable and collectability is reasonable assured.
	Accounts receivables consist of amounts due from customers and are recorded upon the shipment of product to customers. Credit terms are extended to customers in the normal course of business and no collateral is required. The Company estimates an allowance for doubtful accounts based on historical losses, the existing economic conditions and the financial stability of its customers. Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded when received.
Inventory [Policy Text Block]	'
	Inventory
	Inventory is stated at the lower of cost or market value. Cost is determined using the weighted average method, which under the circumstances, management believes will provide for the most practical basis for the measurement of periodic income. Management periodically reviews inventory for slow moving or obsolete items and considers realizability based on the Company’s marketing strategies and sales forecasts to determine if an allowance is necessary. If market value is below cost then an allowance is created to adjust the inventory carrying amount to reflect this.
Equipment [Policy Text Block]	'
	Equipment
	E equipment is recorded at cost. Equipment is depreciated using the straight-line method over the estimated useful lives.
	The estimated useful lives for each asset group are as follows:
			Years
	Furniture and equipment		4
	Computer equipment		2
	At the time depreciable property is retired or otherwise disposed of the related cost and accumulated depreciation is removed from the accounts and any resulting gain or loss is reflected in the consolidated statement of operations.
Intangible Assets [Policy Text Block]	'
	Intangible Assets
	Indefinite-life intangible assets, consisting of costs to acquire trademarks with an indefinite life, are recorded at cost, net of impairment charges, if applicable. No amortization has been taken on indefinite life intangible assets. Indefinite-life intangible assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Website Costs [Policy Text Block]	'
	Website Costs
	The Company recognizes the costs associated with developing a website in accordance with ASC Topic 350–40. Relating to website development costs, the Company follows the guidance pursuant to ASC Topic 350–50.
	Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Internal and external costs incurred to develop internal–use computer software during the application development stage are capitalized. Training costs are not internal–use software development costs and, if incurred during this stage, are expensed as incurred.
	These capitalized costs are amortized based on their estimated useful life over two years.
Impairment of Long-Lived Assets [Policy Text Block]	'
	Impairment of Long-Lived Assets
	The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the related carry amounts may not be recoverable. Such a review involves assessing qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that a long-lived asset is impaired.
	If the Company assesses that there is a likelihood of impairment, then the Company will perform a quantitative analysis comparing the carrying value of the assets with the estimated future net undiscounted cash flows expected to result from the use of the assets, including cash flows from disposition. Should the sum of the expected future net cash flows be less than the carrying value, the Company would recognize an impairment loss at that date for the amount by which the carrying amount of the asset exceeds its fair value. Management has determined that no impairment currently exists.
Shipping and Handling Costs [Policy Text Block]	'
	Shipping and Handling Costs
	Costs associated with the Company’s third-party shipping, warehousing and handling activities are included within operating expenses on the income statement.
		(i)	Shipping costs associated with marketing related promotions are included as a component of general and administrative expenses as office and miscellaneous expense. These shipping costs were $41,696 for the year ended January 31, 2014 ($36,142 for the year ended January 31, 2013).
Advertising Expense [Policy Text Block]	'
	Advertising Expense
	The Company expenses advertising costs to operations during the year in which they were incurred. The Company expensed $60,011 and $68,122 related to advertising for the years ended January 31, 2014 and 2013, respectively.
Income Taxes [Policy Text Block]	'
	Income Taxes
	The current income tax represents the amount of income taxes expected to be paid or the benefit expected to be received for the current year taxable income or loss. Deferred income taxes are recognized for the future tax consequences of temporary differences arising between the carrying value of assets and liabilities for financial statement and tax reporting purposes. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
	In assessing the recoverability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which those temporary differences become deductible. Management considers projected future taxable income and tax planning strategies in making this assessment.
	The Company recognizes the impact of a tax position in the consolidated financial statements if the position is more likely than not to be sustained upon examination on the technical merits of the position. The Company’s policy is to recognize interest accrued related to unrecognized tax benefits and penalties as income tax expense. The Company has no uncertain tax positions as of January 31, 2014 and 2013, respectively; consequently no interest or penalties have been accrued by the Company.
Fair Value of Financial Instruments [Policy Text Block]	'
	Fair Value of Financial Instruments
	The Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, Fair Value Measurements and Disclosures . ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value hierarchy contains three levels of inputs that may be used to measure fair value as follows:
	Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities;
Derivative Financial Instruments [Policy Text Block]	'
	Derivative Financial Instruments
	The Company evaluates its convertible debt and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815 Derivatives and Hedging. These derivatives may be included in these contracts to provide favourable terms to induce investment into the Company while preserving cash flows. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair value is recorded in the consolidated statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.
Use of Estimates [Policy Text Block]	'
	Use of Estimates
	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.
	Actual results could materially differ from those estimates. The most significant estimates made by the Company are those relating to uncollectible receivables, inventory valuation and obsolescence, and product returns.
Loss per share [Policy Text Block]	'
	Loss per share
	Earnings or loss per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted EPS is computed by dividing net income (loss) by the weighted-average of all potentially dilutive shares of common stock that were outstanding during the periods presented.
	The treasury stock method is used in calculating diluted EPS for potentially dilutive stock options and share purchase warrants, which assumes that any proceeds received from the exercise of in-the-money stock options and share purchase warrants, would be used to purchase common shares at the average market price for the period.
	EPS for convertible debt is calculated under the “if-converted” method. Under the if converted method, EPS is calculated as the more dilutive of EPS (i) including all interest (both cash interest and non-cash discount amortization) and excluding all shares underlying the Notes or; (ii) excluding all interest and costs directly related to the convertible debt (both cash interest and non-cash discount amortization) and including all shares underlying the convertible debt. For the years ended January 31, 2014 and 2013, diluted EPS was calculated by including interest expense related to the convertible debt and excluding the shares underlying the convertible debt.
Accounting for Stock-Based Compensation [Policy Text Block]	'
	Accounting for Stock-Based Compensation
	ASC Topic 718, Compensation – Stock Compensation , requires that compensation expense for employee stock-based compensation be recognized over the requisite service period based on the fair value of the award, at the date of grant.
	The Company accounts for the granting of equity based awards to employees using the fair value method whereby all awards to employees will be recorded at fair value on the date of the grant. The fair value of all equity based awards is expensed over their vesting period with a corresponding increase to additional paid in capital. The fair value of equity based awards is estimated using the most recent share offering of the same or similar share classes (approximate market value). Compensation costs for stock-based payments to employees with graded vesting are recognized on a straight-line basis.
	Based on guidance in ASC 505-50, stock-based payments to non-employees are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The fair value of stock-based payments to non-employees is periodically re-measured until the counterparty performance is complete, and any change therein is recognized over the vesting period of the award. Compensation costs for stock-based payments with graded vesting are recognized on a straight-line basis. The cost of the stock-based payments to non-employees that are fully vested and non-forfeitable as at the grant date are measured and recognized at that date, unless there is a contractual term for services in which case such compensation would be amortized over the contractual term.
New Accounting Pronouncements [Policy Text Block]	'
	New Accounting Pronouncements
	There are no new accounting pronouncements that the Company recently adopted or are pending the Company’s adoption that are expected to have a material impact on the Company’s results of operations, financial position or cash flows.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jan. 31, 2014
Revenue from External Customers by Geographic Areas [Table Text Block]	'
			2014			2013
	United States	$	394,867		$	410,012
	Canada		244,240			156,496
		$	639,107		$	566,508
Schedule of Fair Value of Convertible Promissory Notes Using the Black Scholes Option Pricing Model [Table Text Block]	'
			2014	2013
		Risk-free interest rate	0.05%	0.21%
		Expected life (years)	0.36	1.54
		Expected volatility (1)	212.64%	219.86%
		Stock price	$0.08	$0.25
		Dividend yields	0.00%	0.00%
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
			2013			2012
	Numerator
	Net loss	$	(4,238,490	)	$	(1,332,996	)
	Less: Shareholder dividend – Note 14(i)		(239,680	)		-
		$	(4,478,170	)	$	(1,332,996	)
	Denominator
	Weighted average common shares outstanding		31,418,517			20,363,483
	Basic and diluted net loss per share	$	(0.14	)	$	(0.07	)
	Anti-dilutive securities not included in diluted
	loss per share relating to:
	Warrants and options outstanding		6,775,446			4,047,506
	Convertible debt		9,651,379			666,667
			16,426,825			4,714,173

Reverse_Acquisition_Tables

Reverse Acquisition (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	Cash & receivable	$	386,790
	Accounts payable and advances payable		(108,789	)
	Due to a related party		(44,843	)
	Net assets acquired	$	233,158

Inventory_Tables

Inventory (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Inventory, Current [Table Text Block]	'
	January 31,		2014		2013
	Finished goods - Underwear	$	528,461	$	115,709
	Raw materials		75,585		120,441
	Total inventory	$	604,046	$	236,150

Equipment_Tables

Equipment (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Property, Plant and Equipment [Table Text Block]	'
	January 31,		2014			2013
	Furniture & equipment	$	6,630		$	1,380
	Computer equipment		4,534			3,554
	Less: Accumulated depreciation		(4,864	)		(3,092	)
		$	6,300		$	1,842

Intangible_Assets_Tables

Intangible Assets (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	'
								Useful life
			2014			2013		(Years)
	Trade Names/Trademarks	$	24,874		$	23,212		Indefinite
	Website		44,512			40,657		2
			69,386			63,869
	Less: accumulated amortization		(29,509	)		(8,455	)
		$	39,877		$	55,414

Related_Party_Payables_Tables

Related Party Payables (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Related Party Payable [Table Text Block]	'
	January 31,		2014		2013
	Advance, bearing interest at 19.50% per annum	$	-	$	9,603
	Advance, non-interest bearing		-		4,313
			-		13,916
	Less: current portion		-		(13,916	)
		$	-	$	-

Promissory_Notes_Payable_Table

Promissory Notes Payable (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Short-term Debt [Table Text Block]	'
			2014			2013
	Promissory note bearing interest at 10% per annum payable at maturity, unsecured, maturing on February 1, 2014(i)	$	75,000		$	-
	Promissory note in the principal amount of $309,062, non- interest bearing, unsecured, repayable in five equal semi- monthly instalments of $41,667 plus one final balloon payment of $63,229 at its maturity on July 13, 2014. The one-time interest charge of 15% or $37,500 is convertible at maturity, at the option of the holder, into shares of common stock of the Company at a price of $0.10 per share (iii)		309,062
						-
	Promissory note in the principal amount of CDN$16,250, non-interest bearing, repayable in equal instalments of CDN$3,125 over the remaining term of the note, unsecured. The note may be repaid at any time before maturity without notice, bonus or penalty. The final CDN$3,750, representing a 15% original issue discount (“OID”) is repayable upon the company reporting net income from operations in a single month (iv)		14,668			-
	Promissory note in the principal amount of CDN$47,917, non-interest bearing, repayable in equal instalments of CDN$9,583 over the remaining term of the note, unsecured. The note may be repaid at any time before maturity without notice, bonus or penalty (v)		43,250			-
	Less: debt discounts		(44,558	)		-
			397,422			-
	Less: current portion		(397,422	)		-
		$	-		$	-

Convertible_Promissory_Notes_T

Convertible Promissory Notes (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Convertible Promissory Notes Payable [Table Text Block]	'
			2014			2013
	Revolving Credit Facility, bearing interest at 12% per annum, due August 16, 2014(i)	$	500,000		$	500,000
	Revolving Credit Facility, bearing interest at 12% per annum, due January 31, 2014(i)		275,000			-
	Convertible promissory note payable, non-interest bearing, due February 9, 2014(ii)		128,704			-
	Convertible promissory note payable, non-interest bearing, due November 13, 2014(iv) (Note 12)		124,444			-
	Convertible promissory notes, bearing interest at 8% per annum, due September 23, 2014 (v)		91,688			-
	Convertible promissory notes, bearing interest at 8% per annum, due September 17, 2014 (vi)		84,085			-
	Less: debt discounts		(179,957	)		(16,050	)
			1,023,964			483,950
	Less: current portion		(1,022,294	)		(483,950	)
		$	1,670		$	-
At Issuance [Member]	'
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	'
	Risk-free interest rate	0.29%
	Expected life (years)	2.2
	Expected volatility (1)	201.94%
	Estimated stock price at date of issuance (2)	$0.25
	Dividend yields	0.00%
Amended Convertible Promissory Notes [Member]	'
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	'
	Risk-free interest rate	0.10%
	Expected life (years)	1.07
	Expected volatility (1)	151.47%
	Stock price	$0.52
	Dividend yields	0.00%
Modification [Member]	'
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	'
	Risk-free interest rate	1.03%
	Expected life (years)	4.25
	Expected volatility (1)	249.92%
	Stock price at date of issuance	$0.52
	Dividend yields	0.00%
Agents Warrants and Lender Warrants [Member]	'
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	'
	Risk-free interest rate	0.63%
	Expected life (years)	3
	Expected volatility (1)	144.71%
	Stock price at date of issuance	$0.20
	Dividend yields	0.00%
Fair Value of the Finder's Warrants [Member]	'
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	'
	Risk-free interest rate	0.33%
	Expected life (years)	2
	Expected volatility (1)	211.16%
	Stock price at issuance	$0.24
	Dividend yields	0.00%

Derivative_financial_instrumen1

Derivative financial instruments (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	'
		Derivative financial instruments, January 31, 2013	$	-
		Fair values at commitment dates		428,876
		Fair value mark to market adjustments		(9,358	)
		Reclassification of fair value to additional paid-in capital upon extinguishment of host contract		(177,900	)
		Derivative financial instruments, January 31, 2014	$	241,618
Schedule of Assumptions used for Fair Value of Derivative Liabilities [Table Text Block]	'
			January 31,	Extinguishment	Commitment
			2014	date	date
		Risk-free interest rate	0.34%	0.08%	0.27%
		Expected life (years)	1.78	0.76	1.73
		Expected volatility (1)	132.09%	137.74%	157.41%
		Stock price at date of issuance	$0.08	$0.53	$0.51
		Dividend yields	0.00%	0.00%	0.00%

Stockholders_Equity_Tables

Stockholders Equity (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
								Weighted
						Weighted		Average Grant
			Number			Average		Date
			of Options			Exercise Price		Fair Value
	Outstanding at January 31, 2012		-
	Granted		1,885,000		$	0.25	$	0.24
	Outstanding at January 31, 2013		1,885,000		$	0.25
	Granted		1,570,000		$	0.5	$	0.44
	Cancelled		(450,000	)	$	0.5
	Outstanding at January 31, 2014		3,005,000		$	0.34
	Exercisable at January 31, 2014		2,246,184		$	0.38	$	0.27
	Exercisable at January 31, 2013		668,728		$	0.25	$	0.24
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	'
		Exercise	Expiry	Remaining
	Number	Price	Date	Contractual Life
	285,000	$0.25	30-Jul-14	0.49
	20,000	$0.25	1-Feb-15	1
	90,000	$0.25	14-Feb-15	1.04
	15,000	$0.25	25-Jul-15	1.48
	250,000	$0.75	1-Oct-15	1.67
	15,000	$0.25	19-Dec-15	1.88
	150,000	$0.35	6-Jan-16	1.93
	150,000	$0.55	6-Jan-16	1.93
	200,000	$0.75	6-Jan-16	1.93
	30,000	$0.25	1-Apr-16	2.17
	600,000	$0.25	9-Oct-17	3.69
	50,000	$0.25	1-Feb-18	4.01
	150,000	$0.25	1-May-18	4.25
	1,000,000	$0.25	30-Jul-22	8.5
	3,005,000
Schedule of Non-vested Stock Option Activity [Table Text Block]	'
			Number of
			Options
	Non-vested options at January 31, 2012		-
	Granted		1,885,000
	Vested		(668,728	)
	Non-vested options at January 31, 2013		1,216,272
	Granted		1,570,000
	Vested		(1,802,456	)
	Cancelled		(225,000	)
	Non-vested options at January 31, 2014		758,816
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
		2014	2013
	Expected term of stock option (years) (1)	1.48	4.28
	Expected volatility (2)	184.40%	260.50%
	Estimated stock price at date of issuance (3)	$0.71	$0.25
	Risk-free interest rate	0.18%	0.55%
	Dividend yields	0.00%	0.00%
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'
		Exercise	Expiry
	Number	Price	Date
	24,000 *	$0.75	19-Apr-14
	214,506	$0.75	30-Jul-14
	400,000	$0.75	24-Sep-14
	400,000	$0.50	26-Nov-14
	100,000	$0.50	10-Dec-14
	72,000	$0.75	31-Dec-14
	240,000	$0.25	7-Apr-15
	120,000	$0.25	19-Apr-15
	104,440	$0.75	19-Apr-15
	120,000	$0.28	4-Oct-15
	498,000	$0.25	10-Aug-17
	500,000	$0.50	10-Aug-17
	250,000	$0.10	14-Nov-16
	250,000	$0.10	26-Nov-16
	227,500	$0.10	24-Dec-16
	150,000	$0.25	10-Aug-18
	100,000	$0.50	10-Aug-18
	3,770,446
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]	'
								Weighted
			Number of					Average
			Warrants					Exercise Price
	Outstanding at January 31, 2012		100,000			CADS		0.75
	Cancelled		(100,000	)		CAD$		0.75
	Re-issued pursuant to the Acquisition (Note 4)		214,506			USD$		0.75
	Issued		1,948,000			USD$		0.44
	Outstanding at January 31, 2013		2,162,506			USDS		0.47
	Issued		1,609,940			USD$		0.31
	Outstanding at January 31, 2014		3,770,446			USD$		0.4

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Jan. 31, 2014
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	'
	January 31,		2014			2013
			34%			34%
	Loss for the year	$	(4,238,490	)	$	(1,332,996	)
	Expected income tax recovery		(1,441,100	)		(453,200	)
	Effect of change in tax rates		-			(132,800	)
	Non-deductible expenses		394,100			84,700
	Impact of reverse acquisition and emigration on tax assets		-			300,200
	Effect of foreign exchange and other adjustments		(19,700	)		-
	Change in valuation allowance		1,066,700			201,100
	Total income tax expense	$	-		$	-
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
	January 31,		2014			2013
	Temporary differences relating to:
	Net operating loss carry forwards	$	1,049,300		$	309,800
	Incorporation costs and Intangible assets		(7,600	)		(15,100	)
	Stock based compensation		318,300			-
			1,360,500			294,700
	Valuation allowance		(1,360,500	)		(294,700	)
	Net deferred taxes	$	-		$	-

Organization_and_Nature_of_Bus1

Organization and Nature of Business (Narrative) (Details) (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jan. 31, 2014
Organization And Nature Of Business 1	100,000,000
Organization And Nature Of Business 2	$0.00
Organization And Nature Of Business 3	14
Organization And Nature Of Business 4	50.00%

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
	M
Summary Of Significant Accounting Policies 1	50.00%
Summary Of Significant Accounting Policies 2	$41,696
Summary Of Significant Accounting Policies 3	36,142
Summary Of Significant Accounting Policies 4	104,580
Summary Of Significant Accounting Policies 5	45,452
Summary Of Significant Accounting Policies 6	60,011
Summary Of Significant Accounting Policies 7	68,122
Summary Of Significant Accounting Policies 8	1,209,300
Summary Of Significant Accounting Policies 9	$596,000
Summary Of Significant Accounting Policies 10	18.00%
Summary Of Significant Accounting Policies 11	12

Reverse_Acquisition_Narrative_

Reverse Acquisition (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Reverse Acquisition 1	100.00%
Reverse Acquisition 2	13,500,000
Reverse Acquisition 3	100,000
Reverse Acquisition 4	100,000
Reverse Acquisition 5	$0.75
Reverse Acquisition 6	214,506
Reverse Acquisition 7	$0.75
Reverse Acquisition 8	$20,000
Reverse Acquisition 9	50.00%
Reverse Acquisition 10	50.00%
Reverse Acquisition 15	375,000
Reverse Acquisition 16	8,133
Reverse Acquisition 17	$34,951

Accounts_Receivable_Narrative_

Accounts Receivable (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
	D
Accounts Receivable 1	3.75%
Accounts Receivable 2	1.00%
Accounts Receivable 3	28
Accounts Receivable 4	80.00%
Accounts Receivable 5	$31,555
Accounts Receivable 6	6,395
Accounts Receivable 7	$0

Inventory_Narrative_Details

Inventory (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Inventory 1	$18,322
Inventory 2	$0

Equipment_Narrative_Details

Equipment (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Equipment 1	$1,694
Equipment 2	$1,962

Intangible_Assets_Narrative_De

Intangible Assets (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Intangible Assets 1	$21,054
Intangible Assets 2	$9,723

Related_Party_Payables_Narrati

Related Party Payables (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Related Party Payables 1	$13,916
Related Party Payables 2	0
Related Party Payables 3	1,309
Related Party Payables 4	50,000
Related Party Payables 5	0
Related Party Payables 6	24,682
Related Party Payables 7	$0

Promissory_Notes_Payable_Narra

Promissory Notes Payable (Narrative) (Details)	12 Months Ended
	Jan. 31, 2014	Jan. 31, 2014
	USD ($)	CAD
Promissory Notes Payable 1	$75,000	'
Promissory Notes Payable 2	75,000	'
Promissory Notes Payable 3	10.00%	10.00%
Promissory Notes Payable 4	3,750	'
Promissory Notes Payable 5	0	'
Promissory Notes Payable 6	796,850	796,850
Promissory Notes Payable 7	4,850	'
Promissory Notes Payable 8	172,500	'
Promissory Notes Payable 9	4	4
Promissory Notes Payable 10	150,000	'
Promissory Notes Payable 11	21,563	'
Promissory Notes Payable 12	100,000	100,000
Promissory Notes Payable 13	64,000	'
Promissory Notes Payable 14	22,500	'
Promissory Notes Payable 15	86,500	'
Promissory Notes Payable 16	5,000	5,000
Promissory Notes Payable 17	5,000	5,000
Promissory Notes Payable 18	800	'
Promissory Notes Payable 19	86,500	'
Promissory Notes Payable 20	0	'
Promissory Notes Payable 21	309,062	'
Promissory Notes Payable 22	250,000	'
Promissory Notes Payable 23	37,500	'
Promissory Notes Payable 24	15.00%	15.00%
Promissory Notes Payable 25	21,562	'
Promissory Notes Payable 26	41,667	'
Promissory Notes Payable 27	63,229	'
Promissory Notes Payable 28	$0.10	'
Promissory Notes Payable 29	'	28,750
Promissory Notes Payable 30	24,467	24,467
Promissory Notes Payable 31	'	25,000
Promissory Notes Payable 32	15.00%	15.00%
Promissory Notes Payable 33	3,670	'
Promissory Notes Payable 34	'	3,750
Promissory Notes Payable 35	22,000	22,000
Promissory Notes Payable 36	5,720	'
Promissory Notes Payable 37	3,670	'
Promissory Notes Payable 38	9,390	'
Promissory Notes Payable 39	6,110	'
Promissory Notes Payable 40	0	'
Promissory Notes Payable 41	'	57,500
Promissory Notes Payable 42	47,660	'
Promissory Notes Payable 43	'	50,000
Promissory Notes Payable 44	15.00%	15.00%
Promissory Notes Payable 45	7,149	'
Promissory Notes Payable 46	'	7,500
Promissory Notes Payable 47	25,000	25,000
Promissory Notes Payable 48	3,000	'
Promissory Notes Payable 49	7,149	'
Promissory Notes Payable 50	10,149	'
Promissory Notes Payable 51	2,164	'
Promissory Notes Payable 52	$0	'

Convertible_Promissory_Notes_N

Convertible Promissory Notes (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
	D
Convertible Promissory Notes 1	$800,000
Convertible Promissory Notes 2	400,000
Convertible Promissory Notes 3	100,000
Convertible Promissory Notes 4	25,000
Convertible Promissory Notes 5	0.25
Convertible Promissory Notes 6	25,000
Convertible Promissory Notes 7	0.5
Convertible Promissory Notes 8	50,000
Convertible Promissory Notes 9	0.25
Convertible Promissory Notes 10	100,000
Convertible Promissory Notes 11	12.00%
Convertible Promissory Notes 12	$0.75
Convertible Promissory Notes 13	60
Convertible Promissory Notes 14	1.00%
Convertible Promissory Notes 15	4.00%
Convertible Promissory Notes 16	22,100
Convertible Promissory Notes 17	20,940
Convertible Promissory Notes 18	10,462
Convertible Promissory Notes 19	4,890
Convertible Promissory Notes 20	59,618
Convertible Promissory Notes 21	23,208
Convertible Promissory Notes 22	1,148,000
Convertible Promissory Notes 23	948,000
Convertible Promissory Notes 24	448,000
Convertible Promissory Notes 25	$0.25
Convertible Promissory Notes 26	500,000
Convertible Promissory Notes 27	$0.50
Convertible Promissory Notes 28	200,000
Convertible Promissory Notes 29	200,000
Convertible Promissory Notes 30	125,000
Convertible Promissory Notes 31	$0.25
Convertible Promissory Notes 32	75,000
Convertible Promissory Notes 33	$0.50
Convertible Promissory Notes 34	237,500
Convertible Promissory Notes 35	99,694
Convertible Promissory Notes 36	38,962
Convertible Promissory Notes 37	138,656
Convertible Promissory Notes 38	38,962
Convertible Promissory Notes 39	900,000
Convertible Promissory Notes 40	$0.25
Convertible Promissory Notes 41	90.00%
Convertible Promissory Notes 42	60
Convertible Promissory Notes 43	10,000
Convertible Promissory Notes 44	60
Convertible Promissory Notes 45	90
Convertible Promissory Notes 46	0.75
Convertible Promissory Notes 47	$0.50
Convertible Promissory Notes 48	800,000
Convertible Promissory Notes 49	500,000
Convertible Promissory Notes 50	485,704
Convertible Promissory Notes 51	778,553
Convertible Promissory Notes 52	488,849
Convertible Promissory Notes 53	196,000
Convertible Promissory Notes 54	56,555
Convertible Promissory Notes 55	2,520
Convertible Promissory Notes 56	400,000
Convertible Promissory Notes 57	6.00%
Convertible Promissory Notes 58	$0.50
Convertible Promissory Notes 59	$0.25
Convertible Promissory Notes 60	500,000
Convertible Promissory Notes 61	0.5
Convertible Promissory Notes 62	600,000
Convertible Promissory Notes 63	1,200,000
Convertible Promissory Notes 64	$0.15
Convertible Promissory Notes 65	$0.30
Convertible Promissory Notes 66	20
Convertible Promissory Notes 67	30
Convertible Promissory Notes 68	100,000
Convertible Promissory Notes 69	0.5
Convertible Promissory Notes 70	100,000
Convertible Promissory Notes 71	100,000
Convertible Promissory Notes 72	1,868
Convertible Promissory Notes 73	1,018,685
Convertible Promissory Notes 74	$0.10
Convertible Promissory Notes 75	300,000
Convertible Promissory Notes 76	100,000
Convertible Promissory Notes 77	125,000
Convertible Promissory Notes 78	100,000
Convertible Promissory Notes 79	125,000
Convertible Promissory Notes 80	75,000
Convertible Promissory Notes 81	115,000
Convertible Promissory Notes 82	0.1
Convertible Promissory Notes 83	12.00%
Convertible Promissory Notes 84	$0.25
Convertible Promissory Notes 85	362,500
Convertible Promissory Notes 86	0.1
Convertible Promissory Notes 87	17,600
Convertible Promissory Notes 88	100,000
Convertible Promissory Notes 89	58,600
Convertible Promissory Notes 90	41,225
Convertible Promissory Notes 91	17,600
Convertible Promissory Notes 92	58,825
Convertible Promissory Notes 93	58,825
Convertible Promissory Notes 94	0
Convertible Promissory Notes 95	5,531
Convertible Promissory Notes 96	0
Convertible Promissory Notes 97	67,600
Convertible Promissory Notes 98	200,000
Convertible Promissory Notes 99	6.00%
Convertible Promissory Notes 100	600,000
Convertible Promissory Notes 101	76,388
Convertible Promissory Notes 102	1,388
Convertible Promissory Notes 103	343,212
Convertible Promissory Notes 104	300,000
Convertible Promissory Notes 105	42,902
Convertible Promissory Notes 106	$0.25
Convertible Promissory Notes 107	4,859,613
Convertible Promissory Notes 108	200,000
Convertible Promissory Notes 109	48,000
Convertible Promissory Notes 110	5,000
Convertible Promissory Notes 111	15,000
Convertible Promissory Notes 112	2,100
Convertible Promissory Notes 113	83,458
Convertible Promissory Notes 114	0
Convertible Promissory Notes 115	53,054
Convertible Promissory Notes 116	2,500
Convertible Promissory Notes 117	10,000
Convertible Promissory Notes 118	12,125
Convertible Promissory Notes 119	2,400
Convertible Promissory Notes 120	11,429
Convertible Promissory Notes 121	120,000
Convertible Promissory Notes 122	$0.28
Convertible Promissory Notes 123	18,400
Convertible Promissory Notes 124	48,916
Convertible Promissory Notes 125	0
Convertible Promissory Notes 126	48,916
Convertible Promissory Notes 127	0
Convertible Promissory Notes 128	15,000
Convertible Promissory Notes 129	128,704
Convertible Promissory Notes 130	500,000
Convertible Promissory Notes 131	150,000
Convertible Promissory Notes 132	10.00%
Convertible Promissory Notes 133	1.2
Convertible Promissory Notes 134	60.00%
Convertible Promissory Notes 135	25
Convertible Promissory Notes 136	12.00%
Convertible Promissory Notes 137	265,000
Convertible Promissory Notes 138	166,667
Convertible Promissory Notes 139	115,000
Convertible Promissory Notes 140	166,667
Convertible Promissory Notes 141	0
Convertible Promissory Notes 142	500,000
Convertible Promissory Notes 143	100,000
Convertible Promissory Notes 144	10.00%
Convertible Promissory Notes 145	0.265
Convertible Promissory Notes 146	60.00%
Convertible Promissory Notes 147	25
Convertible Promissory Notes 148	90
Convertible Promissory Notes 149	0.00%
Convertible Promissory Notes 150	90
Convertible Promissory Notes 151	12.00%
Convertible Promissory Notes 152	12.00%
Convertible Promissory Notes 153	13,333
Convertible Promissory Notes 154	155,500
Convertible Promissory Notes 155	111,111
Convertible Promissory Notes 156	55,500
Convertible Promissory Notes 157	670
Convertible Promissory Notes 158	0
Convertible Promissory Notes 159	25,000
Convertible Promissory Notes 160	25,000
Convertible Promissory Notes 161	8.00%
Convertible Promissory Notes 162	180
Convertible Promissory Notes 163	55.00%
Convertible Promissory Notes 164	180
Convertible Promissory Notes 165	20.00%
Convertible Promissory Notes 166	180
Convertible Promissory Notes 167	20,455
Convertible Promissory Notes 168	4,456
Convertible Promissory Notes 169	0
Convertible Promissory Notes 170	8,000
Convertible Promissory Notes 171	1,056
Convertible Promissory Notes 172	0
Convertible Promissory Notes 173	1,056
Convertible Promissory Notes 174	0
Convertible Promissory Notes 175	83,500
Convertible Promissory Notes 176	8.00%
Convertible Promissory Notes 177	22.00%
Convertible Promissory Notes 178	180
Convertible Promissory Notes 179	61.00%
Convertible Promissory Notes 180	180
Convertible Promissory Notes 181	15.00%
Convertible Promissory Notes 182	180
Convertible Promissory Notes 183	8,376
Convertible Promissory Notes 184	989
Convertible Promissory Notes 185	0
Convertible Promissory Notes 186	11,500
Convertible Promissory Notes 187	1,320
Convertible Promissory Notes 188	0
Convertible Promissory Notes 189	1,320
Convertible Promissory Notes 190	$0

Derivative_financial_instrumen2

Derivative financial instruments (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Derivative Financial Instruments 1	$170,500
Derivative Financial Instruments 2	0
Derivative Financial Instruments 3	$177,900

Securities_Purchase_Agreement_

Securities Purchase Agreement (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
	M
Securities Purchase Agreement 1	$8,300,000
Securities Purchase Agreement 2	8,300,000
Securities Purchase Agreement 3	24
Securities Purchase Agreement 4	$0.35
Securities Purchase Agreement 5	600,000
Securities Purchase Agreement 6	300,000
Securities Purchase Agreement 7	919,500
Securities Purchase Agreement 8	330,000
Securities Purchase Agreement 9	8,000,000
Securities Purchase Agreement 10	$58,656

Stockholders_Equity_Narrative_

Stockholders Equity (Narrative) (Details)	12 Months Ended
	Jan. 31, 2014	Jan. 31, 2014
	USD ($)	CAD
	Y
Stockholders Equity 1	2.14506	2.14506
Stockholders Equity 2	200,000	200,000
Stockholders Equity 3	14,000	14,000
Stockholders Equity 4	$0.50	'
Stockholders Equity 5	$0.25	'
Stockholders Equity 6	200,000	200,000
Stockholders Equity 7	14,000	14,000
Stockholders Equity 8	$0.75	'
Stockholders Equity 9	239,680	'
Stockholders Equity 10	$1.12	'
Stockholders Equity 11	1,993,000	1,993,000
Stockholders Equity 12	$0.25	'
Stockholders Equity 13	100,000	100,000
Stockholders Equity 14	$0.25	'
Stockholders Equity 15	523,250	'
Stockholders Equity 16	$0.25	'
Stockholders Equity 17	104,440	104,440
Stockholders Equity 18	$0.75	'
Stockholders Equity 19	26,610	'
Stockholders Equity 20	1,000,000	1,000,000
Stockholders Equity 21	$0.25	'
Stockholders Equity 22	250,000	'
Stockholders Equity 23	50,000	'
Stockholders Equity 24	50,000	'
Stockholders Equity 25	50,000	'
Stockholders Equity 26	100,000	'
Stockholders Equity 27	800,000	800,000
Stockholders Equity 28	20,000	20,000
Stockholders Equity 29	$0.25	'
Stockholders Equity 30	600,000	600,000
Stockholders Equity 31	75,000	75,000
Stockholders Equity 32	89,250	'
Stockholders Equity 33	$1.19	'
Stockholders Equity 34	240,000	240,000
Stockholders Equity 35	$0.25	'
Stockholders Equity 36	60,000	'
Stockholders Equity 37	$0.25	'
Stockholders Equity 38	4,304	4,304
Stockholders Equity 39	4,820	'
Stockholders Equity 40	3,701	'
Stockholders Equity 41	$0.26	'
Stockholders Equity 42	25,000	25,000
Stockholders Equity 43	23,992	'
Stockholders Equity 44	'	25,000
Stockholders Equity 45	6,500	'
Stockholders Equity 46	10,099	'
Stockholders Equity 47	15,000	15,000
Stockholders Equity 48	3,750	'
Stockholders Equity 49	$0.25	'
Stockholders Equity 50	29,843	29,843
Stockholders Equity 51	4,500	'
Stockholders Equity 52	3,979	3,979
Stockholders Equity 53	2,089	'
Stockholders Equity 54	0	'
Stockholders Equity 55	25,000	25,000
Stockholders Equity 56	15,000	'
Stockholders Equity 57	13,250	'
Stockholders Equity 58	$0.07	'
Stockholders Equity 59	63,492	63,492
Stockholders Equity 60	40,000	'
Stockholders Equity 61	20,000	'
Stockholders Equity 62	4,444	'
Stockholders Equity 63	$0.07	'
Stockholders Equity 64	75,000	75,000
Stockholders Equity 65	75,000	75,000
Stockholders Equity 66	300,000	300,000
Stockholders Equity 67	18,000	'
Stockholders Equity 68	0	'
Stockholders Equity 69	75,000	75,000
Stockholders Equity 70	$0.24	'
Stockholders Equity 71	450,000	450,000
Stockholders Equity 72	450,000	450,000
Stockholders Equity 73	31,200	'
Stockholders Equity 74	0	'
Stockholders Equity 75	45,000	'
Stockholders Equity 76	13,800	'
Stockholders Equity 77	138.17%	138.17%
Stockholders Equity 78	0.1	'
Stockholders Equity 79	0.40%	0.40%
Stockholders Equity 80	1.53	1.53
Stockholders Equity 81	0.00%	0.00%
Stockholders Equity 82	14,000	14,000
Stockholders Equity 83	$0.50	'
Stockholders Equity 84	7,000	'
Stockholders Equity 85	$0.25	'
Stockholders Equity 86	14,000	14,000
Stockholders Equity 87	200,000	200,000
Stockholders Equity 88	$0.50	'
Stockholders Equity 89	100,000	'
Stockholders Equity 90	$0.75	'
Stockholders Equity 91	$0.25	'
Stockholders Equity 92	200,000	200,000
Stockholders Equity 93	$0.75	'
Stockholders Equity 94	400,000	400,000
Stockholders Equity 95	'	0.25
Stockholders Equity 96	100,686	'
Stockholders Equity 97	'	100,000
Stockholders Equity 98	$0.50	'
Stockholders Equity 99	8,055	'
Stockholders Equity 100	32,000	32,000
Stockholders Equity 101	$0.75	'
Stockholders Equity 102	400,000	400,000
Stockholders Equity 103	'	0.25
Stockholders Equity 104	100,330	'
Stockholders Equity 105	'	100,000
Stockholders Equity 106	100,000	100,000
Stockholders Equity 107	$0.25	'
Stockholders Equity 108	25,000	'
Stockholders Equity 109	$0.50	'
Stockholders Equity 110	2,000	'
Stockholders Equity 111	8,000	8,000
Stockholders Equity 112	$0.75	'
Stockholders Equity 113	400,000	400,000
Stockholders Equity 114	$0.25	'
Stockholders Equity 115	100,000	'
Stockholders Equity 116	8,000	'
Stockholders Equity 117	2.14506	2.14506
Stockholders Equity 118	13,500,000	13,500,000
Stockholders Equity 119	147,062	147,062
Stockholders Equity 120	38,766	'
Stockholders Equity 121	$0.25	'
Stockholders Equity 122	63,321	63,321
Stockholders Equity 123	15,486	'
Stockholders Equity 124	8,238	'
Stockholders Equity 125	21,372	'
Stockholders Equity 126	2,352	'
Stockholders Equity 127	$0.25	'
Stockholders Equity 128	14,006	14,006
Stockholders Equity 129	3,440	'
Stockholders Equity 130	$0.25	'
Stockholders Equity 131	5,400,000	5,400,000
Stockholders Equity 194	0	'
Stockholders Equity 195	0	'
Stockholders Equity 196	0	'
Stockholders Equity 197	0	'
Stockholders Equity 206	715,915	'
Stockholders Equity 207	218,268	'
Stockholders Equity 218	$0.25	'
Stockholders Equity 219	500,000	500,000
Stockholders Equity 220	150,000	150,000
Stockholders Equity 221	1.25	'
Stockholders Equity 222	0.35	'
Stockholders Equity 223	150,000	150,000
Stockholders Equity 224	1.75	'
Stockholders Equity 225	0.55	'
Stockholders Equity 226	200,000	200,000
Stockholders Equity 227	2.25	'
Stockholders Equity 228	0.75	'
Stockholders Equity 229	500,000	500,000
Stockholders Equity 230	$15,700	'
Stockholders Equity 231	0.40%	0.40%
Stockholders Equity 232	1.72	1.72
Stockholders Equity 233	141.53%	141.53%
Stockholders Equity 234	0.00%	0.00%
Stockholders Equity 235	3,770,446	3,770,446

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Income Taxes 1	$1,066,700
Income Taxes 2	201,100
Income Taxes 3	1,666,000
Income Taxes 4	528,000
Income Taxes 5	1,419,000
Income Taxes 6	$385,000

Customer_Concentrations_Narrat

Customer Concentrations (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Customer Concentrations 1	37.00%
Customer Concentrations 2	55.30%
Customer Concentrations 3	$15,462
Customer Concentrations 4	325,530
Customer Concentrations 5	12.00%
Customer Concentrations 6	22.80%
Customer Concentrations 7	$3,821

Related_Party_Transactions_Nar

Related Party Transactions (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Related Party Transactions 1	$56,000
Related Party Transactions 2	0
Related Party Transactions 3	56,700
Related Party Transactions 4	0
Related Party Transactions 5	267,918
Related Party Transactions 6	63,276
Related Party Transactions 7	450,000
Related Party Transactions 8	450,000
Related Party Transactions 9	75,000
Related Party Transactions 10	75,000
Related Party Transactions 11	300,000
Related Party Transactions 12	18,000
Related Party Transactions 13	0
Related Party Transactions 14	75,000
Related Party Transactions 15	$7,500
Related Party Transactions 16	75,000
Related Party Transactions 17	$0.10

Subsequent_Events_Narrative_De

Subsequent Events (Narrative) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Subsequent Events 1	6.00%
Subsequent Events 2	$1,033,796
Subsequent Events 3	828,704
Subsequent Events 4	76,388
Subsequent Events 5	128,704
Subsequent Events 6	1,033,796
Subsequent Events 7	6.00%
Subsequent Events 8	$3,000,000
Subsequent Events 9	90.00%

Revenue_from_External_Customer

Revenue from External Customers by Geographic Areas (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 1	$394,867
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 2	410,012
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 3	244,240
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 4	156,496
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 5	639,107
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 6	$566,508

Schedule_of_Fair_Value_of_Conv

Schedule of Fair Value of Convertible Promissory Notes Using the Black Scholes Option Pricing Model (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 1	0.05%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 2	0.21%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 3	0.36
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 4	1.54
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 5	212.64%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 6	219.86%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 7	$0.08
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 8	$0.25
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 9	0.00%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 10	0.00%

Schedule_of_Earnings_Per_Share

Schedule of Earnings Per Share, Basic and Diluted (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 1	($4,238,490)
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 2	-1,332,996
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 3	-239,680
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 4	0
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 5	-4,478,170
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 6	-1,332,996
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 7	31,418,517
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 8	20,363,483
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 9	-0.14
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 10	-0.07
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 11	6,775,446
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 12	4,047,506
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 13	9,651,379
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 14	666,667
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 15	16,426,825
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 16	$4,714,173

Schedule_of_Recognized_Identif

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Reverse Acquisition Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed 1	$386,790
Reverse Acquisition Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed 2	-108,789
Reverse Acquisition Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed 3	-44,843
Reverse Acquisition Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed 4	$233,158

Schedule_of_Inventory_Current_

Schedule of Inventory, Current (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Inventory Schedule Of Inventory, Current 1	$528,461
Inventory Schedule Of Inventory, Current 2	115,709
Inventory Schedule Of Inventory, Current 3	75,585
Inventory Schedule Of Inventory, Current 4	120,441
Inventory Schedule Of Inventory, Current 5	604,046
Inventory Schedule Of Inventory, Current 6	$236,150

Schedule_of_Property_Plant_and

Schedule of Property, Plant and Equipment (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Equipment Schedule Of Property, Plant And Equipment 1	$6,630
Equipment Schedule Of Property, Plant And Equipment 2	1,380
Equipment Schedule Of Property, Plant And Equipment 3	4,534
Equipment Schedule Of Property, Plant And Equipment 4	3,554
Equipment Schedule Of Property, Plant And Equipment 5	-4,864
Equipment Schedule Of Property, Plant And Equipment 6	-3,092
Equipment Schedule Of Property, Plant And Equipment 7	6,300
Equipment Schedule Of Property, Plant And Equipment 8	$1,842

Schedule_of_Acquired_FiniteLiv

Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 1	$24,874
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 2	23,212
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 3	44,512
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 4	40,657
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 5	2
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 6	69,386
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 7	63,869
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 8	-29,509
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 9	-8,455
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 10	39,877
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 11	$55,414

Schedule_of_Related_Party_Paya

Schedule of Related Party Payable (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Related Party Payables Schedule Of Related Party Payable 1	19.50%
Related Party Payables Schedule Of Related Party Payable 2	$0
Related Party Payables Schedule Of Related Party Payable 3	9,603
Related Party Payables Schedule Of Related Party Payable 4	0
Related Party Payables Schedule Of Related Party Payable 5	4,313
Related Party Payables Schedule Of Related Party Payable 6	0
Related Party Payables Schedule Of Related Party Payable 7	13,916
Related Party Payables Schedule Of Related Party Payable 8	0
Related Party Payables Schedule Of Related Party Payable 9	-13,916
Related Party Payables Schedule Of Related Party Payable 10	0
Related Party Payables Schedule Of Related Party Payable 11	$0

Schedule_of_Shortterm_Debt_Det

Schedule of Short-term Debt (Details)	12 Months Ended
	Jan. 31, 2014	Jan. 31, 2014
	USD ($)	CAD
Promissory Notes Payable Schedule Of Short-term Debt 1	10.00%	10.00%
Promissory Notes Payable Schedule Of Short-term Debt 2	$75,000	'
Promissory Notes Payable Schedule Of Short-term Debt 3	0	'
Promissory Notes Payable Schedule Of Short-term Debt 4	309,062	'
Promissory Notes Payable Schedule Of Short-term Debt 5	41,667	'
Promissory Notes Payable Schedule Of Short-term Debt 6	63,229	'
Promissory Notes Payable Schedule Of Short-term Debt 7	15.00%	15.00%
Promissory Notes Payable Schedule Of Short-term Debt 8	37,500	'
Promissory Notes Payable Schedule Of Short-term Debt 9	$0.10	'
Promissory Notes Payable Schedule Of Short-term Debt 10	309,062	'
Promissory Notes Payable Schedule Of Short-term Debt 11	0	'
Promissory Notes Payable Schedule Of Short-term Debt 12	'	16,250
Promissory Notes Payable Schedule Of Short-term Debt 13	'	3,125
Promissory Notes Payable Schedule Of Short-term Debt 14	'	3,750
Promissory Notes Payable Schedule Of Short-term Debt 15	15.00%	15.00%
Promissory Notes Payable Schedule Of Short-term Debt 16	14,668	'
Promissory Notes Payable Schedule Of Short-term Debt 17	0	'
Promissory Notes Payable Schedule Of Short-term Debt 18	'	47,917
Promissory Notes Payable Schedule Of Short-term Debt 19	'	9,583
Promissory Notes Payable Schedule Of Short-term Debt 20	43,250	'
Promissory Notes Payable Schedule Of Short-term Debt 21	0	'
Promissory Notes Payable Schedule Of Short-term Debt 22	-44,558	'
Promissory Notes Payable Schedule Of Short-term Debt 23	0	'
Promissory Notes Payable Schedule Of Short-term Debt 24	397,422	'
Promissory Notes Payable Schedule Of Short-term Debt 25	0	'
Promissory Notes Payable Schedule Of Short-term Debt 26	-397,422	'
Promissory Notes Payable Schedule Of Short-term Debt 27	0	'
Promissory Notes Payable Schedule Of Short-term Debt 28	0	'
Promissory Notes Payable Schedule Of Short-term Debt 29	$0	'

Schedule_of_Convertible_Promis

Schedule of Convertible Promissory Notes Payable (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 1	12.00%
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 2	$500,000
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 3	500,000
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 4	12.00%
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 5	275,000
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 6	0
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 7	128,704
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 8	0
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 9	124,444
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 10	0
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 11	8.00%
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 12	91,688
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 13	0
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 14	8.00%
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 15	84,085
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 16	0
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 17	-179,957
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 18	-16,050
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 19	1,023,964
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 20	483,950
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 21	-1,022,294
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 22	-483,950
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 23	1,670
Convertible Promissory Notes Schedule Of Convertible Promissory Notes Payable 24	$0

Schedule_of_Fair_Value_of_the_

Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
At Issuance [Member]	'
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	0.29%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	2.2
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	201.94%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	$0.25
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	0.00%
Amended Convertible Promissory Notes [Member]	'
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	0.10%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	1.07
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	151.47%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	0.52
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	0.00%
Modification [Member]	'
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	1.03%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	4.25
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	249.92%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	0.52
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	0.00%
Agents Warrants and Lender Warrants [Member]	'
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	0.63%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	3
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	144.71%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	0.2
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	0.00%
Fair Value of the Finder's Warrants [Member]	'
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	0.33%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	2
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	211.16%
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	$0.24
Convertible Promissory Notes Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	0.00%

Schedule_of_Derivative_Liabili

Schedule of Derivative Liabilities at Fair Value (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 1	$0
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 2	428,876
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 3	-9,358
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 4	-177,900
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 5	$241,618

Schedule_of_Assumptions_used_f

Schedule of Assumptions used for Fair Value of Derivative Liabilities (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 1	0.34%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 2	0.08%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 3	0.27%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 4	1.78
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 5	0.76
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 6	1.73
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 7	132.09%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 8	137.74%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 9	157.41%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 10	$0.08
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 11	0.53
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 12	$0.51
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 13	0.00%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 14	0.00%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 15	0.00%

Schedule_of_Sharebased_Compens

Schedule of Share-based Compensation, Stock Options, Activity (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 1	$0
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 2	1,885,000
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 3	0.25
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 4	0.24
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 5	1,885,000
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 6	0.25
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 7	1,570,000
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 8	0.5
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 9	0.44
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 10	-450,000
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 11	0.5
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 12	3,005,000
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 13	0.34
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 14	2,246,184
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 15	0.38
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 16	0.27
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 17	$668,728
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 18	0.25
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 19	0.24

Disclosure_of_Sharebased_Compe

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1	$285,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3	0.49
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4	20,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6	1
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7	90,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9	1.04
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10	15,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12	1.48
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13	250,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14	0.75
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15	1.67
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16	15,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18	1.88
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19	150,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20	0.35
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21	1.93
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22	150,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23	0.55
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 24	1.93
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 25	200,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 26	0.75
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 27	1.93
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 28	30,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 29	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 30	2.17
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 31	600,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 32	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 33	3.69
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 34	50,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 35	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 36	4.01
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 37	150,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 38	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 39	4.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 40	1,000,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 41	0.25
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 42	8.5
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 43	$3,005,000

Schedule_of_Nonvested_Stock_Op

Schedule of Non-vested Stock Option Activity (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Stockholders Equity Schedule Of Non-vested Stock Option Activity 1	$0
Stockholders Equity Schedule Of Non-vested Stock Option Activity 2	1,885,000
Stockholders Equity Schedule Of Non-vested Stock Option Activity 3	-668,728
Stockholders Equity Schedule Of Non-vested Stock Option Activity 4	1,216,272
Stockholders Equity Schedule Of Non-vested Stock Option Activity 5	1,570,000
Stockholders Equity Schedule Of Non-vested Stock Option Activity 6	-1,802,456
Stockholders Equity Schedule Of Non-vested Stock Option Activity 7	-225,000
Stockholders Equity Schedule Of Non-vested Stock Option Activity 8	$758,816

Schedule_of_Sharebased_Payment

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1	1.48
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2	4.28
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3	184.40%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4	260.50%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5	$0.71
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6	$0.25
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7	0.18%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8	0.55%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 9	0.00%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 10	0.00%

Schedule_of_Stockholders_Equit

Schedule of Stockholders' Equity Note, Warrants or Rights (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 1	$24,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 2	0.75
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 3	214,506
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 4	0.75
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 5	400,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 6	0.75
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 7	400,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 8	0.5
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 9	100,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 10	0.5
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 11	72,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 12	0.75
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 13	240,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 14	0.25
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 15	120,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 16	0.25
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 17	104,440
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 18	0.75
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 19	120,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 20	0.28
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 21	498,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 22	0.25
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 23	500,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 24	0.5
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 25	250,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 26	0.1
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 27	250,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 28	0.1
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 29	227,500
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 30	0.1
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 31	150,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 32	0.25
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 33	100,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 34	0.5
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 35	$3,770,446

Schedule_of_Stockholders_Equit1

Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1	$100,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2	0.75
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3	-100,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4	0.75
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5	214,506
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6	0.75
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 7	1,948,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 8	0.44
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 9	2,162,506
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 10	0.47
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 11	1,609,940
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 12	0.31
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 13	$3,770,446
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 14	0.4

Schedule_of_Components_of_Inco

Schedule of Components of Income Tax Expense (Benefit) (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 1	34.00%
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 2	34.00%
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 3	($4,238,490)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 4	-1,332,996
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 5	-1,441,100
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 6	-453,200
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 7	0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 8	-132,800
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 9	394,100
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 10	84,700
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 11	0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 12	300,200
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 13	-19,700
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 14	0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 15	1,066,700
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 16	201,100
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 17	0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 18	$0

Schedule_of_Deferred_Tax_Asset

Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1	$1,049,300
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2	309,800
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3	-7,600
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4	-15,100
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5	318,300
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6	0
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7	1,360,500
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8	294,700
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9	-1,360,500
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10	-294,700
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11	0
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12	$0